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To the millions of people suffering from alcohol abuse and dependence and to 
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Ethanol is a widely used drug, yet an understanding of its sites and mechanisms of 
action remains incomplete.  Among the protein targets of ethanol are glycine receptors 
(GlyRs).  In addition to ethanol, zinc also modulates GlyR function.  Although the 
individual effects of zinc and alcohols on GlyR function have been well studied, the 
combined effects of these agents have not been thoroughly examined.  This project 
investigated the effects of zinc on alcohol action at the glycine receptor (GlyR).  In Aim 
1, the effects of zinc on ethanol modulation of GlyR function were tested and 
characterized in three GlyR α subunits (α1-3).  Aim 2 explored a site of action for the 
augmenting effects of zinc on ethanol action at the GlyR.  Mutant D80A GlyRs, which 
lack a zinc binding site (D80), were constructed and allowed us determine if this zinc 
binding site is important for the zinc/ethanol interactions that were observed in Aim 1.  
The effects of ethanol were reduced in mutant D80A GlyRs compared to wild type (WT).  
In addition, manipulating zinc levels in our buffers either by adding or chelating zinc did 
not change the magnitude of ethanol enhancement of mutant D80A GlyRs as it did in WT 
GlyRs suggesting that the D80 position is important for zinc modulation of ethanol 
action.  Finally, Aim 3 extended the findings from Aims 1 and 2 by evaluating the effects 
of a GlyR point-mutation on alcohol consumption and other behavioral tests in mice.  
Glra1(D80A) knock-in mice provided an animal model for behavioral studies of 
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zinc/ethanol interactions at the GlyR and showed decreased alcohol consumption and 
preference compared to their WT littermates. In addition, D80A KI mice had increased 
startle responses compared to their WT littermates. Other behavioral tests were also 
conducted including tests of ethanol motor incoordination and strychnine induced 
convulsions; there were no differences detected between KI and WT mice in these assays.  
Overall, our findings demonstrate that zinc is critical in determining the effects of ethanol 
at GlyRs and suggest that zinc signaling at the D80 position may be important for 
mediating the behavioral effects of ethanol action at GlyRs. 
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CHAPTER I: Background and Significance 
Human consumption of alcohol for its intoxicating effects has been a 
practice of people since prehistoric times, yet the complex biochemical actions of 
this drug that produce its physiological effects remain poorly understood today.  
As a sedative hypnotic agent, alcohol produces a progressive series of 
physiological and subjective behavioral changes that occur with increasing blood 
alcohol concentrations.  At low blood alcohol concentrations, intoxicated 
individuals may experience reductions in anxiety, disinhibition, and ‘social 
lubrication’ (increased talkativeness, assertiveness, and eloquence), whereas at 
moderate blood alcohol concentrations, impairments in judgment, cognition, and 
motor function may be evident in addition to signs of marked ataxia, impaired 
reaction time, and blackouts.  Finally, at high blood alcohol concentrations, 
individuals demonstrate increased sedation/hypnosis, and approach anesthesia and 
coma.  The LD50 (or lethal dose for 50% of people) for alcohol is about 0.40 
gm% (Koob and Le Moal, 2006).  For comparison, the legal level for intoxication 
in the United States is 0.08 gm%.   
Affecting all parts of the brain, alcohol specifically impacts coordination 
via action in the cerebellum, activates the mesolimbic dopamine system resulting 
in reward, and influences the function of cortical regions involved in impulsivity 
and decision-making (Roberts and Koob, 1997).  The acute effects of alcohol are 
reversible in contrast to the persistent effects of chronic alcohol exposure.  
Repeated alcohol use can result in the development of alcohol tolerance, and 
periods of abstinence following chronic use can result in withdrawal symptoms, 
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which are two of the hallmark symptoms of alcoholism.  Alcohol craving and a 
loss of control or inability to stop drinking are additional symptoms of this 
chronic, relapsing, and cureless disease. A number of other known alcohol-related 
toxicities and medical complications can occur with alcohol use, such as sexual 
dysfunctions, amenorrhea, liver damage/cirrhosis, heart disease, cancer, 
neuropsychiatric disorders (i.e. Wernicke’s encephalopathy and Korsakaff’s 
psychosis), and fetal alcohol syndrome (for review, Koob and Le Moal, 2006).  
Although ethanol is among the most widely used drugs, our understanding 
of the molecular targets to which it binds to produce its intoxicating effects 
remains incomplete. One widely accepted idea is that ethanol acts at specific 
membrane proteins in the central nervous system.  In a recent review, Harris et al. 
(2008) outline a set of criteria that qualifies a substrate as a molecular target of 
alcohol.  Among the strongly-supported protein targets are glycine receptors 
(GlyRs), which mediate the majority of inhibitory neurotransmission in the brain 
stem and spinal cord (Legendre, 2001), but are also expressed in the hippocampus 
(Fatima-Shad and Barry, 1993), nucleus accumbens (Martin and Siggins, 2002; 
Molander and Soderpalm, 2005), amygdala (Delaney et al., 2010), olfactory bulb 
(van den Pol and Gorces, 1988), and cerebellum (Takahashi et al., 1992).  In 
addition to ethanol (and other alcohols), several other pharmacologically-active 
agents, including volatile anesthetics and inhaled drugs of abuse, enhance GlyR 
function via allosteric modulation (Mihic et al., 1997; Beckstead et al., 2000).  
Zinc, which exists endogenously in brain both in protein-bound and free forms, 
also allosterically modulates GlyR function but does so in a biphasic manner such 
that concentrations less than 10 µM produce enhancing effects, and those greater 
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than 10 µM inhibit GlyR function (Bloomenthal et al., 1994; Harvey et al., 1999; 
Laube et al., 2000).  Although the individual effects of zinc and alcohols on GlyR 
function have been well studied, the combined effects of these agents have not 
been thoroughly examined such that previous investigations have largely 
neglected the potential role of endogenous agents such as zinc in ethanol receptor 
pharmacology.  
GLYCINE RECEPTORS AND ALCOHOL 
GlyRs are anion-conducting members of the nicotinic acetylcholine 
superfamily of ligand-gated ion channels.  Four α subunits (1-4), with 80-90% 
sequence identity among subunits, and a single β subunit, possessing ~50% 
sequence identity with the α subunits, have been identified (Lynch, 2004).   GlyR 
subunits can assemble to form either homomeric or heteromeric pentamers 
containing an integral ion pore.  Each subunit contains extracelluar N- and C-
terminal regions, a large intracellular loop, and four alpha helical segments (TM1-
4), which collectively constitute a transmembrane domain (Figure 1.1).   
Cysteine substitution experiments in the α1 GlyR at serine-267 (S267) in TM2 
and alanine-288 (A288) in TM3, involving covalent thiol binding or cross-linking, 
suggest an alcohol and anesthetic binding pocket within the transmembrane 
domain of each subunit (Mascia et al., 2000; Lobo et al., 2006; 2008).  
Specifically, S267 and A288 were initially shown to be essential in GlyR 
enhancement by these agents (Mihic et al., 1997), and more recently it has been 
shown that mutation of the neighboring positions Q266 and M287 also eliminates 
potentiation of GlyR function by ethanol (Borghese et al., 2012).  Furthermore, 
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findings from a series of studies indicate that amino acid residues in the TM1 and 
TM4 helices may also participate in alcohol and anesthetic binding (Lobo et al., 
2004; 2006; 2008; McCracken et al., 2010).   
Additional putative alcohol binding sites on the α1 GlyR have also been 
suggested.  These include alanine-52 (A52), which is in Loop 2 of the N-terminal 
domain (Davies et al., 2004; Crawford et al., 2008), as well as lysine-385 (K385) 
of the large intracellular loop linking TM3 and TM4 (Yvenes et al., 2008).  The 
latter residue has also been suggested to be involved in GlyR modulation by Gβγ 
(Yvenes et al., 2003). 
 Although less sensitive to the effects of alcohol than the α1 subunit, α2 
GlyR function is also enhanced by ethanol, and of the GlyR α subunits it 
predominates in limbic brain regions affected by ethanol (McCool et al., 2003). 
The differences in alcohol sensitivity between the α1 and α2 subunits may reflect 
the presence of non-homologous residues in the N-terminal domain.  For 
example, α1A52S GlyRs resemble wild type α2 receptors in their sensitivity to 
ethanol (i.e. the α1 A52S mutant is less sensitive than α1 wild type) (Mascia et 
al., 1996).  Because sensitivity to the effects of alcohols has not been published 
for α3 and α4 subunits, comparisons of the relative magnitude of the effects of 





Figure 1.1: 3D structure of a pentameric ligand-gated ion channel.   
The extra-cellular domain (ECD) is shown in red, the transmembrane domain 
(TMD) is depicted in purple, and the intra-cellular loop or cytoplasmic domain 
(CD) is displayed in green.  Because X-ray crystal structures have not been solved 
for GlyRs, homology models of GlyR structure are generated using related 
proteins of known structure as templates.  This illustration is based on the known 
structure of the Torpedo nicotinic acetylcholine receptor (adapted from Baenziger 
& Corringer, 2011).   
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Recent single channel analysis of ethanol modulation of GlyR function has 
revealed that ethanol potentiates receptor function by increasing burst durations 
and the number channel openings per burst.  In addition, kinetic modeling 
suggests this is likely due to ethanol decreasing glycine unbinding from the 
receptor (Welsh et al., 2009). 
Behavioral studies in rodents have revealed a possible role for GlyRs in 
alcohol consumption.  For example, microdialysis of glycine into the nucleus 
accumbens increases extracellular accumbal dopamine levels, and this is 
accompanied by a decrease in alcohol consumption by alcohol-preferring Wistar 
rats; in contrast, the GlyR antagonist strychnine produces opposite effects 
(Molander et al., 2005).  Strychnine, applied via microdialysis, prevents increases 
in accumbal dopamine levels after either local or systemic alcohol administration 
(Molander and Soderpalm, 2005).  Furthermore, in line with these findings, the 
glycine reuptake inhibitor, Org 25935, has been shown to decrease ethanol, but 
not water intake, as well as ethanol preference (Molander et al., 2007).   
GLYCINE RECEPTORS AND ZINC 
Although zinc concentrations in the brain exceed those present in other 
organs, most zinc is protein-bound (Mathie et al. 2006).  In its free or rapidly 
exchangeable form, zinc exists in cerebospinal fluid at tonic baseline 
concentrations ranging from approximately 5-25 nM (Frederickson et al. 2006). 
Present in higher concentrations in the grey than in the white matter, zinc is most 
abundant in forebrain areas including the hippocampus, amygdala, and neocortex 
(Slomianka et al., 1990; Frederickson & Moncrieff, 1994; Takeda et al., 2000).  In 
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the CNS, neurons secrete zinc (Takeda et al., 2001), which is predicted to remain 
at concentrations up to 10 μM following presynaptic release from GABAergic, 
glutamatergic, or glycinergic terminals (Frederickson et al. 2001).  In its free and 
loosely bound forms zinc has been localized in synaptic vesicles containing zinc 
transporters, ZnT3 and ZnT4, which are required for its neuronal transport 
(Harris, 2002).  Vesicular zinc is often found in GABAergic or glutamatergic 
neurons, and the localization of zinc in the terminals of these neurons follows 
regional patterns. Specifically, zinc-enriched GABAergic terminals are found in 
the cerebellum (Wang et al. 2002), whereas glutamatergic terminals containing 
vesicular zinc predominate in the cerebral cortex, amygdalar nuclei, olfactory 
bulb, and the hippocampal formation (Frederickson & Bush, 2001), which notably 
also contain the GlyR subunits α1, α2, and α3.  In addition to brain, glycine and 
zinc have been co-localized at synapses in the spinal cord (Birinyi et al., 2001).   
Although the mechanism for zinc modulation of GlyR function is not 
completely understood, several amino acid residues located in the N-terminal 
domain of the α1 subunit responsible for the enhancing and inhibiting effects of 
zinc on GlyR function have been identified (Table 1). The potentiating effects of 
zinc, generally seen at concentrations in the nanomolar to low micromolar range 
(<10 μM), require high-affinity binding to amino acids at positions aspartate-80 
(D80), threonine-151 (T151), glutamate-192 (E192), aspartate-194 (D194), and 
histidine-215 (H215) (Laube et al. 2000; Miller et al. 2005b). Additional residues 
of the GlyR α1 subunit, in particular histidine-107 (H107), histidine-109 (H109), 
threonine-112 (T112), and threonine-133 (T133) are thought to contribute to 
lower-affinity binding sites and are necessary for inhibition of GlyR function by 
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higher micromolar concentrations of zinc (> 10 μM) (Harvey et al., 1999; Laube 
et al., 2000; Miller et al., 2005). The importance of zinc binding at lower affinity 
(GlyR inhibitory) sites is illustrated in instances of ischemia, seizure, trauma, and 
neurodegeneration, during which zinc levels are estimated to peak in the brain at 
concentrations in excess of 100 μM (Choi & Koh,1998; Doraiswamy & 
Finefrock, 2004). 
Alignment of the amino acid sequences for the GlyR α1, α2, and α3 
subunits reveal that while most of the positions that have been demonstrated to be 
important for GlyR modulation by zinc are conserved across all three subunits, 
there are positions that are not (see Table 1).  For example, all of the putative zinc 
binding positions in the α1 GlyR are conserved at the homologous positions in the 
α2 and α3 subunits except for H107 in α1, which is asparagine-114 (N114) and 
asparagine-107 (N107) in α2 and α3 respectively.  The significance of this 
difference can be seen such that homomeric α1 GlyRs are more sensitive to zinc 
inhibition than homomeric α2 or α3 GlyRs, but mutation of histidine-107 to 
asparagine results in an α1 H107N mutant that is less sensitive to zinc inhibition 
resembling α2 and α3 (Miller et al., 2005).  In addition, D194 in α1 and α3, is not 
conserved at the homologous position in α2, which is glutamate-201 (E201).  
Studies of the enhancing effects of zinc on GlyRs have revealed the potential 
importance of this site in zinc binding and action.  Homomeric α2 GlyRs are less 
sensitive to the potentiating effects of zinc than are homomeric α1 or α3 GlyRs.  
However, mutation of E-201 to aspartate (E201D) in α2 results in a mutant GlyR 
that is more sensitive to zinc enhancement, and thus resembles wild type α1 and 
α3 GlyRs (Miller et al., 2005).   
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α1 D80 H107* H109 T112 T133 T151 E192 D194 H215 
α2 D87 N114 H116 T119 T140 T158 E199 E201* H222 
α3 D80 N107 H109 T112 T133 T151 E192 D194 H215 
Table 1:  Zinc binding positions on GlyR subunits. 
 Alignment of the amino acid sequences for the α1, α2, and α3 GlyR subunits 
reveal that of the known putative zinc binding sites at the GlyR all are conserved 
in these three subunits except for two positions (*), H107 in α1 and E201 in α2.  
Amino acid residues displayed in green are important for high-affinity zinc 
binding and enhancement of GlyR function, whereas those denoted in red are 
critical for low-affinity zinc binding and inhibition of GlyR function.   
 10 
Several lines of evidence highlight the physiological relevance of free zinc 
in the CNS and its ability to modulate GlyR function there. For example, the 
significance of zinc to normal GlyR function was recently demonstrated in 
knockin mice carrying a D80A mutation in the GlyR α1 subunit gene (Glra1) 
(Hirzel et al., 2006).  Mice homozygous for Glra1 (D80A) exhibit phenotypes 
analogous to human startle disease, and in vitro studies of spinal neurons and 
brainstem slices from these animals reveal significant impairments in the 
enhancement of spontaneous glycinergic currents by zinc (Hirzel et al., 2006). In 
addition, basal concentrations (low nanomolar) of zinc found in the CNS are 
sufficient for the prolongation of the decay phase of glycinergic miniature 
inhibitory postsynaptic currents (Suwa et al., 2001).  
Single channel kinetic analysis of potentiation of GlyR function by low 
concentrations of zinc have shown that like ethanol zinc enhances GlyR function 
by increasing the frequency of channel opening and increasing burst durations 
(Laube et al., 2000). 
Although the individual effects of zinc and alcohols as modulators of 
GlyR function have been well studied, the combined effects of these agents have 
not been thoroughly examined such that most studies have largely neglected the 
potential role of endogenous agents such as zinc in ethanol receptor 
pharmacology.  
However, emergent evidence from in vitro investigations in the α1 subunit 
suggest that zinc is critical for ethanol enhancement of GlyR function by 
intoxicating concentrations of ethanol.  
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Specifically, McCracken et al. (2010) demonstrated that low nanomolar 
concentrations of zinc both enhanced responses to submaximal concentrations of 
glycine and increased ethanol enhancement of GlyR function (Figure 1.2).  In 
addition, chelation of free zinc by tricine decreased the potency of submaximal 
concentrations of glycine and reduced the magnitude of ethanol’s effect on GlyR 
function indicating the importance of zinc in determining the sensitivity of GlyRs 
to ethanol (Figure 1.3).  Subsequently, careful pharmacological characterization 
of a GlyR α1 mutant (M287L) with decreased ethanol sensitivity revealed that 
although enhancement of the mutant by zinc alone was retained, zinc did not 
enhance the effects of ethanol on the mutant receptor at low nanomolar 
concentrations that were suffice for increasing the magnitude of ethanol 
enhancement of receptor function in wild type GlyRs (Borghese et al., 2012).   
GLYCINE RECEPTOR MUTANT MICE 
Receptor knock-in (KI) mice, containing a single point mutation, serve as 
a powerful tool to examine the effects of ethanol on the CNS.  In such mice, all 
other aspects of the receptor of interest function normally, which diminishes the 
likelihood of compensation by other receptor types and subunits.  To date, 
multiple behavioral pharmacological studies of ethanol action in GlyR mutant 
mice have been conducted, but have been limited to mice carrying mutations in 
the GlyR α1 subunit gene (Glra1) that correspond to single amino acid 
substitutions (S267Q, Q266I, and M287L) in the alpha helical segments of the 
transmembrane domain.  In addition, homozygous KI mice carrying each of the 
Glra1 S267Q, Q266I, and M287L mutations are not viable, and therefore all 
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ethanol-related behavioral tests of these mutations have been additionally limited 
to heterozygous animals (Findlay et al., 2003; Blednov et al., 2012).  Despite most 
homozygous GlyR KI mice not being viable, one exception is the Glra1 D80A KI 
animal, which contains a point mutation at a putative high affinity zinc binding 
site located in the N-terminal domain.  
Preliminary non-ethanol related behavioral characterizations of 
homozygous Glra1 D80A mice reveal that enhancement of GlyR function by 
endogenous zinc is critical for normal neurological function (Hirzel et al., 2006).  
The availability of D80A mice affords the opportunity to study the potential role 
of zinc signaling at GlyRs in modulating alcohol drinking and other alcohol-
related behaviors.   
In an alternative approach, transgenic expression of α1 S267Q GlyRs in 
mice under the control of synapsin I regulatory sequences have been developed 
and studied in alcohol-related behavioral tests.  Although these mice have been 
helpful in demonstrating the importance of normal glycine receptor function in 
many alcohol-related behaviors, the transgenic approach is overall inferior to the 
KI approach in that the latter uses endogenous promoters to drive expression, 
which therefore more closely resembles wild type cellular distributions.    
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Figure 1.2: The effects of added zinc on ethanol action at the glycine receptor.  
A) 200 mM ethanol was first co-applied with 10 μM glycine and then was 
reapplied after a washout period with both 10 μM glycine and 50 nM zinc. B) The 
amount of absolute current produced by 200 mM ethanol was significantly greater 
when it was applied during a concurrent application of 50 nM zinc + 10 μM 
glycine than when it was applied with 10 μM glycine alone (adapted from 




Figure 1.3: The effects of zinc chelation on Glycine receptor sensitivity to glycine 
and ethanol. 
Glycine concentration-response curves and EtOH enhancement of EC5-10 glycine 
responses were determined before and after application of 10 mM tricine.  A) 
Tricine did not affect the currents elicited by a maximally-effective concentration 
of glycine (10 mM) although it did increase the glycine EC50 from 139 µM to 
315 µM; i.e., it only decreased the effects of submaximal glycine concentrations. 
B) Tricine significantly decreased the degree of GlyR enhancement by 50 mM 
and 200 mM ethanol (adapted from McCracken et al., 2010).   
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 ALCOHOL-RELATED BEHAVIORAL TESTING OF MUTANT MICE 
Several behavioral paradigms have been developed, adapted, and validated 
for testing alcohol consumption and other ethanol-related behaviors in rodent 
animal models.  For example, the 24-hour access two-bottle choice alcohol 
drinking paradigm, which was developed several decades ago, has been used in 
innumerable tests aimed at identifying genetic determinants of, as well as the 
effects of voluntary ethanol consumption in rodents (Crabbe et al., 1984).  
In addition to tests of voluntary alcohol drinking, several other behavioral 
measures of ethanol action have specifically been used in characterizing the 
behavioral phenotypes of GlyR mutant mice.   For example, duration of LORR 
has been often used in tests of sensitivity to ethanol and other sedative agents 
including in studies of mice with GlyR mutations (Findlay et al., 2005; Blednov et 
al., 2012).  Furthermore, acoustic startle responses have been characterized in 
both homozygous and heterozygous GlyR KI mice with and without ethanol 
(Findlay et al., 2003; Hirzel et al., 2006; Blednov et al., 2012).  Because 
strychnine is a known antagonist of GlyR function, measurements of strychnine-
induced convulsions in mice containing GlyR mutations are important in 
determining the behavioral effects of such mutations.  Previous studies of mice 
with GlyR mutations have not only measured strychnine-induced seizure activity, 
but some also have measured ethanol inhibition of strychnine convulsions 
(Findlay et al., 2002; Blednov et al., 2012).  
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GAPS IN OUR KNOWLEDGE 
Despite the contributions of studies that have investigated the effects of 
zinc and/or ethanol on GlyR function, several unknowns still exist.  First, initial 
findings from McCracken et al. (2010) suggest that zinc enhances the effects of 
ethanol at GlyRs, however, it is unknown whether zinc enhancement of ethanol 
action at GlyRs is due to zinc binding and action at known zinc binding sites or 
whether this effect is due to zinc action at novel positions.  In vitro investigations 
of the effects of ethanol on α1 D80A GlyRs provide a reasonable starting point 
for such studies as this position is among the N-terminal domain sites known to be 
important for the enhancement of GlyR function by zinc. In addition, because 
Glra1 D80A KI mice are viable, they provide an animal model for alcohol-related 
behavioral studies of the effects of zinc signaling at GlyRs.  Such knowledge is 
essential for understanding how ethanol enhances GlyR function, and this more 
broadly could provide more accurate approximations of ethanol’s effects in vivo.  
In addition, little work has focused on the GlyR α3 subunit, and unlike the α1 or 
α2 subunits, the effects of ethanol on the α3 subunit, which is distributed in 
nociceptive neurons of the spinal cord dorsal horn (Harvey et al., 2004), the 
amygdala (Delaney et al., 2010), the nucleus accumbens (Jonsson et al., 2009), 
the hippocampus (Meier et al., 2005), the retina (Haverkamp et al., 2003) as well 
as other CNS systems, remain unknown at this time.  This pattern of expression of 
the α3 GlyR subunit in the CNS suggests it may be important in motivation, 
learning, memory, and other cognitive processes, which are impacted by exposure 
to ethanol, and thus warrants inclusion in studies of alcohol action. This 
dissertation contains three aims that each contribute to the overall goal of 
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providing a more thorough understanding of ethanol’s action at GlyRs.  Aim 1 
characterizes zinc/ethanol interactions at three GlyR subunits (α1, α2, α3), and 
Aim 2 explores a site of action for such an interaction using GlyRs containing 
mutations at putative zinc binding sites.  Finally, Aim 3 investigates the 
behavioral effects of ethanol in KI mice containing GlyR mutations at a putative 
zinc binding site (D80A).   
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CHAPTER II: Zinc-dependent Modulation of α2 and α3 Glycine 
Receptor Subunits by Ethanol 
INTRODUCTION 
Although ethanol is among the most prevalently used drugs, the sites and 
mechanisms of action by which it produces its intoxicating effects are not 
thoroughly understood.  One widely accepted idea is that ethanol acts at protein 
targets in the body.  Among the strongly- supported protein targets of ethanol are 
strychnine-sensitive glycine receptors (GlyRs) (Harris et al., 2008), which belong 
to the Cys-loop superfamily of ligand-gated ion channels.  Like other members of 
this channel family that also includes nicotinic acetylcholine receptors, GABA-A 
receptors, as well as serotonin-3 receptors, GlyRs are pentameric proteins 
containing an integral channel pore.   
There are four known GlyR alpha subunits (α1, α2, α3, and α4) and one 
known GlyR beta subunit (Lynch et al., 2004).  GlyRs can assemble to form 
either homomeric or heteromeric chloride channels that mediate inhibitory 
neurotransmission in the central nervous system where they are localized most 
abundantly in the spinal cord and brainstem (Legendre et al., 2001), but are also 
expressed appreciably throughout the brain in many regions including the cortex, 
hippocampus, amygdala, nucleus accumbens, striatum, ventral tegmental area, 
and cerebellum (Takahashi et al., 1992; Jonsson et al., 2009; Baer et al., 2009).   
Identified as one of the strongly-supported molecular substrates of ethanol, 
GlyRs are not only modulated by alcohols, but also by volatile anesthetics, and 
inhaled drugs of abuse, which all act to enhance receptor function (Mihic et al., 
1997; Beckstead et al 2002; Harris et al., 2008).  In addition to these exogenous 
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agents, endogenous cations such as zinc, also allosterically modulate GlyR 
function.  Unlike the exogenous sedative hypnotics that strictly enhance GlyR 
function, zinc produces biphasic effects on GlyR function such that nanomloar 
and low micromolar concentrations enhance glycine-activated currents, whereas 
higher micromolar concentrations of zinc inhibit GlyR function (Bloomenthal et 
al., 1994; Laube et al., 2000; Miller et al., 2005).  In addition, recent in vitro work 
in the GlyR α1 subunit has shown that zinc at physiological (nanomolar) 
concentrations enhances the magnitude of ethanol’s effects on GlyR function 
(McCracken et al., 2010).    
Although the effects of ethanol on the α1 GlyR subunit have been 
relatively well studied, much less work has focused on the GlyR α2 subunit, and 
presently there are no published reports of ethanol modulation of the GlyR α3 
subunit despite that both α2 and α3 GlyR subunits are expressed in a number of 
brain regions involved in ethanol consumption and other ethanol-related 
behaviors (Jonsson et al., 2009).  More specifically, in limbic and motivation 
centers of the brain, such as the amygdala and nucleus accumbens, studies of gene 
and receptor membrane expression demonstrate that there is greater abundance of 
α2 and α3 than α1 subunits in these regions suggesting the importance of studies 
to better characterize the effects of ethanol on these particular GlyRs (Delaney et 
al., 2010; Jonsson et al., 2009).   
In addition to differences in brain region expression among GlyR alpha 
subunits, there is emergent evidence suggesting some functional differences as 
well.   For example, subpopulations particularly of α3 subunits undergo RNA 
editing that results in α3P185L receptors.  These edited subunits confer high 
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sensitivity to agonists such as glycine (Meier et al., 2005; Legendre et al., 2009), 
which seems to be functionally important for tonic inhibition (Eichler et al., 
2009).  Recent studies of RNA editing largely focus on α3 GlyRs, but there is 
some evidence for a similar post-translational modification in α2 GlyRs as well 
(Eichler et al., 2008). 
Due to their localization in limbic, motivation, and reward-related brain 
areas, thorough studies of the effects of ethanol at α2 and α3 GlyRs are necessary 
and relevant for better understanding the mechanism by which ethanol exerts its 
physiological effects.  In addition, because zinc exists is the CNS at tonic baseline 
levels in the low nanomolar range (Frederickson et al., 2006), which is sufficient 
for enhancement of GlyR function and critical for determining the magnitude of 
ethanol’s effects on α1 GlyRs, it is important to investigate the role of zinc in 
ethanol modulation of α2 and α3 GlyR subunits.  Furthermore, emergent 
information about the significance of RNA edited GlyRs in CNS inhibition 
suggests that comparisons of ethanol sensitivity between edited and unedited 
receptors may be important for a thorough understanding of ethanol action.   
In the current study, we tested the hypothesis that the magnitude of 
ethanol’s effects on α2 and α3 GlyR subunits like α1 subunits would be enhanced 
in the presence of physiologically relevant concentrations of zinc.  Because the 
effects of ethanol on α3 GlyRs have not been previously studied, sensitivity to 
ethanol had to be first confirmed in this subunit.  A secondary goal of this study 
was to subsequently determine whether or not there are differences in ethanol 
sensitivity between edited and unedited α3 GlyRs. 
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MATERIALS AND METHODS 
Materials 
All chemical reagents (tricine, zinc chloride, ethanol, glycine) and 
Modified Barth’s Solution (MBS) buffer constituents (NaCl, KCl, NaHCO3, 
HEPES, MgSO4) were purchased from Sigma-Aldrich (St. Louis, MO).  Xenopus 
laevis frogs were purchased from Xenopus Express (Brooksville, FL). 
cDNA Constructs and Site-directed Mutagenesis 
Glycine receptor α2 (human) and α3 (rat) subunit clones (both in pCis2 
vectors) were obtained from Dr. N. Harrison and Dr. H. Betz, respectively.  A 
mutant α3 GlyR was created by substituting the proline at position 185 with 
leucine in order to create an α3P185L mutant GlyR that corresponds to RNA 
edited GlyRs occurring in vivo.  The mutagenesis reaction was carried out using a 
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) and 
commercially engineered mutagenic primers (Integrated DNA Technologies, San 
Diego, CA).  Successful mutagenesis was confirmed using DNA sequencing at 
The University of Texas DNA Core Facility (Austin, TX).   
Xenopus Oocyte Preparation 
Partial ovariectomies were performed on sexually mature female Xenopus 
laevis, and ovary fragments were placed in isolation media (108 mM NaCl, 2 mM 
KCl, 1 mM EDTA, 10 mM HEPES).  Stage IV and V oocytes were manually 
extracted from the thecal and epithelial membranes with forceps under a light 
microscope.  In order to remove the follicular membrane, isolated oocytes were 
immersed in 0.5 mg/ml collagenase in collagenase buffer (83 mM NaCl, 2 mM 
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KCl, 1 mM MgCl2 ) for 10 minutes and then were transferred into MBS (88 mM 
NaCl, 1 mM KCl, 2.4 mM NaHCO3 , 10 mM HEPES, 0.82 mM MgSO4 , 0.33 mM 
Ca(NO3)2 , 0.91 mM CaCl2) for cDNA injection. 
The animal pole of each oocyte was injected with (1.5 ng / 30 nl) either 
α2, wild type α3, or mutant α3P185L GlyR cDNA using an automated injector 
interfaced to a foot switch (Drummond Nanoinject II, Broomall, NY).  Injected 
oocytes were incubated individually in 96-well plates filled with incubation media 
(MBS, 2 mM Na pyruvate, 0.5 mM theophylline, 10 U/ml penicillin, 10 mg/l 
streptomycin, 50 mg/l gentamycin) and were stored in the dark at 13C until 
electrophysiology recordings were performed approximately 1-7 days following 
injection. 
Two-Electrode Voltage Clamp Electrophysiology 
For electrophysiology recordings, oocytes were impaled in the animal 
poles with two high-resistance (>1 MΩ) glass electrodes containing 3N KCl and 
were voltage-clamped at -70mV using a Warner OC-725C oocyte clamp (Warner 
Instruments, Hamden, CT).  A Masterflex USA peristalsis pump (Cole-Parmer 
Instrument Corporation, Vernon Hills, IL) was used to deliver MBS to oocytes via 
bath perfusion at a rate of 2 ml/min.  Clamping currents were recorded on 
LabChart Pro software (Colorado Springs, CO), which was interfaced to the 
oocyte voltage-clamp apparatus via a PowerLab 4/30 data acquisition system (AD 
Instruments, Colorado Springs, CO).   
Glycine concentration-response curves.  Glycine concentration response 
curves were generated for oocytes expressing α2 and α3 GlyRs.  For wild type 
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receptors, a series of glycine concentrations (10 µM- 100 mM) were tested.  Each 
respective concentration of glycine was applied for ~30 sec and a 7 min washout 
period followed each application.  The concentration of glycine that elicited the 
largest response was determined to be maximal, and the effects of the remaining 
glycine concentrations were calculated and recorded as a percent of the maximal 
glycinergic effect.  To determine the effects of zinc chelation on sensitivity to 
glycine, the same protocol was repeated in a buffer solution containing 10 mM 
tricine.  Similarly, to determine the effects of added zinc on glycine responses, the 
same glycine response curve protocol was again repeated, but in the presence of 1 
µM zinc added to the buffer solution.  Because α3P185L GlyRs are known to 
confer very high sensitivity to glycine (Legendre et al.,), this difference in glycine 
sensitivity between wild type α3 and α3P185L GlyRs was confirmed by 
generating concentration-response curves as described above.  However, a wider 
range of glycine concentrations was tested (100 nM- 100 mM) due to published 
reports of edited α3 GlyRs conferring significantly higher affinity for glycine than 
wild type channels (Meier et al., 2005; Legendre et al., 2009). 
Ethanol sensitivity in the absence and presence of zinc. Oocytes were first 
perfused with two ~15 sec applications of 10 mM glycine each followed by a 7 
min washout period.  The peak current elicited by the second application of 
glycine was considered to be the maximal response and was used to determine a 
concentration of glycine that produced ~5-10% (EC5-10) of the maximal 
glcyinergic effect.  This experimentally derived EC5-10 concentration of glyince 
was then applied and following a 7 min washout period, ethanol was first applied 
alone for 1 min, then it was applied concurrently with the experimentally derived 
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EC5-10 concentration of glycine for ~45 sec.  The EC5-10 concentration of 
glycine was again applied alone for 45 sec following a 7 min washout.  This 
procedure was used to test the effects of a series of ethanol concentrations (20, 50, 
100, and 200 mM).  To determine the effects of chelating contaminating zinc on 
ethanol modulation of α2 and α3 GlyRs, we repeated the same protocol in the 
presence of 10 mM Tricine, which was added to the buffer solution (as previously 
described in McCracken et al., 2010).  In addition, to test the hypothesis that 
added zinc would produce the opposite effect of a zinc chelator, we repeated the 
procedure for testing ethanol sensitivity a third time in a buffer solution 
containing 500 nM added zinc.  In all three conditions, the effects of ethanol were 
determined as percent potentiation of the glycine EC5-10 response.    
Ethanol sensitivity in edited α3 GlyRs.  To preliminarily screen for 
potential differences in ethanol sensitivity between edited and unedited α3 GlyRs, 
the above protocol was used to test the effects of 20 mM, 50 mM, and 200 mM 
ethanol on wild type α3 and mutant α3P185L GlyRs in standard MBS buffer 
solution.   
DATA ANALYSIS 
Nonlinear regression analyses were performed to calculate glycine EC 50 
values and Hill coefficients for glycine concentration-response curves, and one-
way ANOVAs followed by Tukey’s post-hoc analyses were used to determined 
differences in ethanol sensitivity.  Overall, statistical differences were determined 
at p< 0.05, and all analyses were conducted using GraphPad PRISM software 
(San Diego, CA). 
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RESULTS 
For wild type α2 and α3 GlyRs, manipulating zinc levels shifted the 
respective glycine concentration-response curves of both subunits.  More 
specifically, Figure 2.1 shows that adding 1 µM zinc, which is an approximately 
maximally enhancing concentration of zinc (Bloomenthal et al., 1994), resulted in 
leftward shifts, whereas chelating contaminating zinc with tricine resulted in 
slight rightward shifts.  In addition, neither adding nor removing zinc from our 
MBS buffers changed the maximal glycine-activated currents for either α2 or α3 
GlyRs. 
Recently, we reported that the effects of ethanol on wild type α1 GlyRs 
are zinc dependent (McCracken et al., 2010), and in this study we sought to test 
the hypothesis that zinc is also critical in determining the magnitude of ethanol’s 
effects on α2 and α3 GlyRs.  First, we tested the effects of ethanol (20, 50, 100, 
and 200 mM) on these GlyRs in standard MBS and then subsequently in the 
presence of the zinc chelating agent tricine as well as in the presence of 500 nM 
added zinc.  Figure 2.2 shows that chelating contaminating zinc with tricine 
decreased ethanol enhancement of α2 GlyR function.  In contrast, the magnitude 
of the effects of ethanol was significantly greater in the presence of 500 nM added 
zinc [F(6, 45)= 3.76; 0.0041].  Because there are no published reports of ethanol 
modulation of α3 GlyRs, we first tested the hypothesis that the α3 GlyR subunit 
like the α1 and α2 subunits is sensitive to the effects of ethanol.  Figure 2.3 shows 
that α3 GlyRs confer concentration-dependent sensitivity to a range of ethanol 
concentrations (20- 200 mM).   
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Figure 2.1. Glycine Responses in the presence of tricine. 
Glycine concentration- response curves were generated for α2 and α3 GlyRs.  A) 
The responses of α2 GlyRs to a series of glycine concentrations (10 µM-10 mM) 
in standard MBS, MBS with 10 mM trcine, and MBS with 1 µM added zinc.  B) 
The responses of α3 GlyRs to glycine (10 µM-100 mM) in MBS, MBS with 10 
mM tricine, and MBS with 1 µM added zinc.   
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After confirming ethanol enhancement of α3 GlyRs, we subsequently investigated 
whether or not the effects of ethanol are modulated by zinc as they are in α1 and 
α2 GlyRs.  Chelating contaminating zinc resulted in decreased effects of ethanol, 
whereas adding 500 nM zinc increased the magnitude of ethanol enhancement of 
α3 GlyR function [F(6,33)= 4.51; p= 0.0019] (Figure 2.3).  Recent findings 
indicate that some α3 GlyRs undergo RNA editing resulting in α3P185L GlyRs 
with high agonist sensitivity (Meier et al., 2005; Legendre et al., 2009).  Our goal 
was to test for differences in ethanol sensitivity between wild type α3 GlyRs and 
α3P185L GlyRs containing a proline to leucine substitution that corresponds to 
RNA editing α3 GlyRs occurring in vivo.  First, we generated glycine 
concentration-response curves for both wild type and mutant α3 GlyRs to confirm 
that our mutant contained high glycine sensitivity consistent with previous 
findings.  Figure 2.4A shows the P185L mutation indeed resulted in GlyRs with 
significantly leftward shifted glycine concentration-response curves.  However, 
the maximal glycine-activated currents were not significantly different.  Next, we 
tested for differences in ethanol sensitivity between wild type and mutant α3 
GlyRs.  Figure 2.4B shows that the effects of 20 and 50 mM ethanol on wild type 
and mutant α3P185L GlyRs were not significantly different [for 20 mM ethanol: 
t(3)= 0.5891; p> 0.05; for 50 mM ethanol: t(3)= 0.3352; p> 0.05].   However, the 
effects of 200 mM ethanol were greater in wild type compared to mutant α3 
GlyRs [t(3)= 4.155; p< 0.05].   
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Figure 2.2: Ethanol modulation of α2 glycine receptors.   
Ethanol modulation of submaximal glycine responses (EC5) was tested in α2 
GlyRs.  The effects of a series of ethanol concentrations (20, 50, 100, and 200 
mM) were tested in standard MBS (containing contaminating levels of nanomolar 
zinc), in the presence of the zinc chelator tricine (no free zinc), and in MBS with 
500 nM added zinc.   
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Figure 2.3: Ethanol modulation of α3 glycine receptors. 
Ethanol sensitivity was confirmed in α3 GlyRs.  The percent potentiation of 
submaximal (EC5) glycine responses by ethanol (20, 50, 100, 200 mM) was 
tested in standard MBS (containing nanomolar zinc contamination), in MBS plus 





Zinc, which exists endogenously in the CNS at basal low nanomolar 
concentrations (Frederickson et al., 2006), allosterically modulates GlyR function 
such that nanomolar and low micromolar (< 10 µM) concentrations produce 
enhancement of glycine-activated currents, whereas higher micromolar 
concentrations of zinc (> 10 µM) produce GlyR inhibition (Bloomenthal et al., 
1994; Harvey et al., 1999; Laube et al., 2000).  In this study, manipulation of 
enhancing concentrations of zinc in our buffer solutions either by chelating zinc 
with tricine or by adding zinc resulted in changes in the effects of submaximal but 
not maximal concentrations of glycine on α2 and α3 GlyRs.  This is consistent 
with previous findings in the α1 subunit (McCracken et al., 2010) and provides 
further evidence that low concentrations of zinc enhance GlyR function via 
allosteric modulation.   
In the present study, we tested the hypothesis that the magnitude of 
ethanol’s effect on α2 and α3 GlyRs is modulated by low physiological 
concentrations of zinc.  We found that chelating contaminating zinc in our 
buffers, which we previously tested and reported to be less than 50 nM 
(McCracken et al., 2010), resulted in reduced effects of ethanol, whereas adding 
500 nM zinc augmented the modulation of both α2 and α3 GlyRs by ethanol.  
This result is consistent with the enhancing effects of zinc on ethanol modulation 
of wild type α1 GlyRs that we previously reported (McCracken et al., 2010).  
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Figure 2.4: Glycine and ethanol sensitivity in α3P185L GlyRs. 
A)Glycine concentration-response curves were generated for mutant α3P185L 
and wild type α3 GlyRs.  Responses to a series of glycine concentrations (100 
nM- 100 mM) were tested. B) The effects of ethanol (20, 50, and 200 mM) on 
submaximal glycine-activiated currents (EC5 glycine) were tested in wild type α3 
and α3P185L GlyRs.  
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 In addition, the overall importance of physiological zinc in determining the 
magnitude of ethanol’s effect on GlyRs is further demonstrated in a recent study 
of a mutant α1 GlyR (M287L) with reduced sensitivity to ethanol.  Although 
enhancement of α1M287L GlyRs by zinc alone is retained, zinc does enhance the 
effects of ethanol on the mutant receptor at nanomolar concentrations that suffice 
for increasing the magnitude of ethanol enhancement of receptor function in wild 
type GlyRs (Borghese et al., 2012). 
The mechanisms for zinc modulation of GlyR function are not completely 
understood, but several amino acid residues located in the GlyR N-terminal 
domain seem to be key for the enhancing and inhibiting effects of zinc on GlyR 
function (Table 1). The potentiating effects of zinc, generally seen at 
concentrations in the nanomolar to low micromolar range (<10 μM), require high-
affinity binding to amino acids distinct from those that have been identified as 
crucial for the inhibitory effects of concentrations of zinc in the higher 
micromolar range (> 10 µM) (Laube et al. 2000; Miller et al. 2005b).  Notably, 
these higher (inhibitory) concentrations of zinc in the CNS are not tonically 
present, but may be achieved in instances of ischemia, seizure, trauma, and 
neurodegeneration (Choi & Koh,1998; Doraiswamy & Finefrock, 2004).  For the 
purposes of this study, we focused on lower (nanomolar) enhancing 
concentrations of zinc that correspond more closely to zinc levels basally present 
in cerebrospinal fluid (Frederickson et al., 2006).   
Alignment of the amino acid sequences for the GlyR α1, α2, and α3 
subunits reveal that while most of the positions that have been demonstrated to be 
important for GlyR modulation by zinc are conserved across all three subunits, 
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there are positions that are not (see Table 1).  For example, all of the putative zinc 
binding positions in the α1 GlyR are conserved at the homologous positions in the 
α2 and α3 subunits except for H107 in α1, which is asparagine-114 (N114) and 
asparagine-107 (N107) in α2 and α3 respectively.  The significance of this 
difference can be seen such that homomeric α1 GlyRs are more sensitive to zinc 
inhibition than homomeric α2 or α3 GlyRs, but mutation of histidine-107 to 
asparagine results in an α1 H107N mutant that is less sensitive to zinc inhibition 
resembling α2 and α3 (Miller et al., 2005).  In addition, D194 in α1 and α3, is 
not conserved at the homologous position in α2, which is glutamate-201 (E201).  
Studies of the enhancing effects of zinc on GlyRs have revealed the potential 
importance of this site in zinc binding and action.  Homomeric α2 GlyRs are less 
sensitive to the potentiating effects of zinc than are homomeric α1 or α3 GlyRs.  
However, mutation of E-201 to aspartate (E201D) in α2 results in a mutant GlyR 
that is more sensitive to zinc enhancement, and thus resembles wild type α1 and 
α3 GlyRs (Miller et al., 2005).  Despite the reported differences in zinc 
modulation of GlyR alpha subunits, it is important to note that nanomolar 
concentrations of zinc enhance ethanol’s effects generalizes for all three alpha 
subunits (α1, α2, and α3) tested in this study and in our previous work.  
Cysteine substitution experiments in the α1 GlyR at serine-267 (S267) in 
TM2 and alanine-288 (A288) in TM3, involving covalent thiol binding or cross-
linking, suggest an alcohol and anesthetic binding pocket within the 
transmembrane domain of each subunit (Mascia et al., 2000; Lobo et al., 2006; 
2008).  Specifically, S267 and A288 were initially shown to be essential in GlyR 
enhancement by these agents (Mihic et al., 1997), and more recently it has been 
 34 
shown that mutation of the neighboring positions Q266 and M287 also eliminates 
potentiation of GlyR function by ethanol (Borghese et al., 2012).  Furthermore, 
findings from a series of studies indicate that amino acid residues in the TM1 and 
TM4 helices may also participate in alcohol and anesthetic binding (Lobo et al., 
2004; 2006; 2008; McCracken et al., 2010).   
Additional sites important for alcohol action on the α1 GlyR have also 
been suggested.  These include alanine-52, which is in Loop 2 of the N-terminal 
domain (Mascia et al., 1996; Davies et al., 2004; Crawford et al., 2008), as well as 
lysine-385 (K385) of the large intracellular loop linking TM3 and TM4 (Yvenes 
et al., 2008).  
Although less sensitive to the effects of alcohol than the α1 subunit, α2 
GlyR function is also enhanced by ethanol, and of the GlyR alpha subunits it 
predominates in limbic brain regions affected by ethanol (McCool et al., 2003). 
The differences in alcohol sensitivity between the α1 and α2 subunits may reflect 
the presence of non-homologous residues in the N-terminal domain.  For 
example, α1 GlyRs containing an alanine to serine substitution at position 52 
(A52S) resemble wild type α2 receptors in their sensitivity to ethanol (i.e. the α1 
A52S mutant is less sensitive than α1 wild type) (Mascia et al., 1996).  In this 
study, we demonstrated that the α3 GlyR subunit does confer sensitivity to 
ethanol and that this effect is zinc-dependent.  Although further investigations of 
alcohol modulation of α3 GlyRs are needed, it appears that modulation of the α3 
GlyR subunit by zinc and ethanol is quite similar to the effects of these agents on 
the α1 GlyR subunit and may reflect the close homology of residues important for 
both the effects of ethanol and zinc. 
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An additional aim of this study was to test α3 GlyRs for differences in 
ethanol sensitivity between unedited and RNA edited receptors.  We used site-
directed mutagenesis to created an α3P185L GlyR that corresponds to RNA 
edited receptors occurring in vivo.  Although we did not detect differences in the 
effects of low concentrations of ethanol (20 and 50 mM) on wild type and mutant 
α3P185L GlyRs, the edited receptors may be of interest for future investigations 
of the effects of lower concentrations of ethanol on Cys-loop receptors.  Previous 
findings, as well as ours, show that the P185L receptors show higher affinity for 
glycine than unmodified or wild type α3 GlyRs (Meier et al., 2005; Legendre et 
al., 2009), and emergent evidence also suggests that RNA edited GlyRS are 
located non-synaptically (Eichler et al., 2009).  In addition, sequence alignment 
with other members of the Cys-loop family reveal that the only other subunit that 
endogenously contains a leucine at the position homologous to 185 in GlyR α3 is 
the GABAA α6 subunit.  However, there is functional homology at this position 
with the GABAA α6 and δ subunits, which also contain aliphatic residues, valine 
and alanine respectively, at this position.  Like α3 GlyRs, these GABAA receptor 
subunits have high agonist sensitivities and are important for inhibitiory 
neurotransmission outside of the synapse (Belelli et al., 2009).  Although 
controversial, there are reports that these GABAA receptor subunits contain 
increased sensitivities to low concentrations of ethanol relative to other GABAA 
receptors (Wallner et al., 2003; 2006; Borghese et al., 2005).  Consequently, 
further studies of edited versus unedited α3 GlyRs may contribute valuable 
insights. 
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In conclusion, our findings demonstrate that like α1 and α2 GlyRs, α3 
GlyRs are modulated by ethanol.  In this study we show that the effects of ethanol 
on α2 and α3 GlyRs are zinc-dependent, as we have previously reported for α1 
GlyRs.  Furthermore, we provide evidence that it is critical to control for zinc 
levels in in vitro investigations of ethanol action at GlyRs.  Finally, our findings 
suggest that accounting for the effects of zinc on ethanol action at GlyRs is 
important for understanding the sites and mechanisms of alcohol action as this 
may ultimately help contribute to improved treatments for alcohol use disorders.   
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CHAPTER III:  Mutation of a Zinc Binding Position (D80) on the 
α1 Glycine Receptor Subunit Changes Ethanol Sensitivity In 
Vitro and Alcohol Consumption In Vivo  
INTRODUCTION 
Strychnine-sensitive glycine receptors (GlyRs) are members of the Cys-
loop superfamily of ligand-gated ion channels.  Expressed in many brain regions 
including the cortex, hippocampus, amygdala, nucleus accumbens, striatum, 
ventral tegmental area (Jonsson et al., 2009; Baer et al., 2009), brain stem 
(Legendre, 2001), and cerebellum (Takahashi et al., 1992), as well as in the spinal 
cord (Legendre, 2001), GlyRs mediate inhibitory neurotransmission in the central 
nervous system (Legendre, 2001).   
There are four known GlyR α subunits (α1, α2, α3, and α4) that are 
transcribed and translated from four distinct genes (glra1, glra2, glra3 and glra4) 
and one known β subunit (β from glrb) (Lynch et al., 2004), which can assemble 
to form pentameric homomers or heteromers containing an integral chloride 
channel.  Structurally, each subunit contains a large extracellular N-terminus, an 
extracellular C-terminus, a large intracellular loop, and four transmembrane 
segments that collectively constitute a transmembrane domain.   
Several agents act as allosteric modulators to enhance GlyR function 
including ethanol (and other alcohols), volatile anesthetics, and inhaled drugs of 
abuse (Mihic et al., 1997; Beckstead 2002).  In addition to these exogenous 
modulators, endogenous agents like zinc, which is present in cerebrospinal fluid 
at tonic baseline concentrations in the low nanomolar range (Frederickson et al., 
2006) also modulate GlyR function.  However, it does so in a biphasic manner 
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such that nanomolar and low micromolar concentrations of zinc enhance GlyR 
function, whereas higher micromolar zinc concentrations produce inhibition 
(Bloomenthal et al., 1994; Laube et al., 1999; Miller et al., 2005).    
In addition to modulating glycine-activated currents, recent evidence from 
in vitro investigations of recombinant GlyRs suggests that zinc also modulates 
ethanol action at GlyRs.  More specifically, zinc chelation by tricine decreases the 
magnitude of ethanol enhancement of α1 GlyRs, whereas addition of 
physiologically relevant nanomolar concentrations of zinc enhances the 
magnitude of ethanol’s effect at GlyRs (McCracken et al., 2010). However, the 
sites and mechanisms of action by which zinc and ethanol interact to modulate 
GlyR function are not presently understood and warrant further exploration.   
Several lines of evidence highlight the physiological relevance of free zinc 
in the CNS and its ability to modulate GlyR function in the brain and spinal cord.  
Most notably are Glra1D80A knock-in (KI) mice, which contain a point mutation 
at a putative high affinity zinc binding site (D80) located in the N-terminal 
domain of the α1 GlyR subunit (Figure 3.1).  Preliminary behavioral 
characterizations of mice homozygous for Glra1D80A reveal that they exhibit 
phenotypes analogous to human startle disease, and in vitro studies of spinal 
neurons and brainstem slices from these animals demonstrate significant 
impairments in the enhancement of spontaneous glycinergic currents by zinc 
(Hirzel et al., 2006).  The availability of D80A mice affords the opportunity to 
study the potential role of zinc signaling at GlyRs in modulating alcohol drinking 





Figure 3.1:  The D80 position of the α1 glycine receptor.   
A schematic representation of an α1 GlyR subunit highlighting the aspartate 
residue at position 80 (D80; shown as red and gray spheres) in the N-terminal 
domain.  In the absence of a GlyR X-ray crystal structure, homology modeling 
(based on the 2BG9 structure) was used to generate this illustration (Courtesy of 
Dr. James R. Trudell).  
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In the present study, we sought to investigate whether the high-affinity 
zinc binding position, D80, on the α1 GlyR subunit is important for the enhancing 
effects of zinc on ethanol modulation of GlyR function.  We first conducted in 
vitro experiments using two-electrode voltage clamp electrophysiology to test the 
effects of ethanol, zinc, and other sedative agents on mutant α1D80A GlyRs 
expressed in Xenopus oocytes.  Next, using the Glra1D80A KI mouse as an 
animal model, we evaluated the effects of a zinc-insensitive GlyR mutation on 
alcohol consumption and other related behavioral tests in mice.  The combination 
of these in vitro and in vivo techniques were used to test the hypothesis that 
disruption of zinc signaling at GlyRs would produce changes in the effects of 
ethanol.   
MATERIALS AND METHODS 
Site-directed Mutagenesis 
Site-directed mutagenesis was used to introduce a single point mutation in 
GlyR α1 cDNA to create the α1D80A mutant GlyR.  This was accomplished 
using a QuikChange mutagenesis kit (Stratagene, La Jolla, CA) and commercially 
engineered mutagenesis primers (Integrated DNA Technology, San Diego, CA).  
Successful mutagenesis was verified using automated fluorescent DNA 
sequencing (The University of Texas at Austin DNA Core Facility, Austin, TX).   
Xenopus Oocyte Isolation and cDNA Injection 
Partial ovariectomies were performed on sexually mature female Xenopus 
laevis obtained from Xenopus Express (Brooksville, FL).  Manual isolation of 
individual oocytes from ovary fragments, cDNA injection of isolated oocytes, and 
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incubation of injected oocytes were performed as previously described 
(McCracken et al., 2010).   
Two-electrode Voltage Clamp Electrophysiology  
For electrophysiology recordings, oocytes were impaled in the animal 
poles with two high-resistance (>1 MΩ) glass electrodes containing 3 M KCl and 
were voltage-clamped at -70mV using a Warner OC-725C oocyte clamp (Warner 
Instruments, Hamden, CT).  A Masterflex USA peristalsis pump (Cole-Parmer 
Instrument Corporation, Vernon Hills, IL) was used to deliver buffer solutions to 
oocytes via bath perfusion at a rate of 2 ml/min.  Clamping currents were 
recorded on LabChart Pro software (Colorado Springs, CO), which was interfaced 
to the oocyte voltage-clamp apparatus via a PowerLab 4/30 data acquisition 
system (AD Instruments, Colorado Springs, CO).  Recordings were performed on 
oocytes expressing wild type α1 or mutant α1D80A mutant GlyRs approximately 
one to seven days post injection.  All electrophysiology protocols were run using 
Modified Barth’s Solution (MBS; 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3 , 
10 mM HEPES, 0.82 mM MgSO4 , 0.33 mM Ca(NO3)2 , 0.91 mM CaCl2) in 
oocytes harvested from at least two different frogs.  
Glycine Concentration-Response Curves.  Glycine concentration-response 
curves were generated for oocytes expressing α1 and α1D80A GlyRs by 
measuring the chloride currents elicited by a series of glycine concentrations (10 
µM-100 mM).  Each concentration of glycine was applied for ~30 sec and was 
followed by a 7 min washout.  The concentration of glycine that elicited the 
largest response was determined to be maximal, and the effects of the remaining 
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glycine concentrations were calculated and recorded as a percent of the maximal 
glycinergic effect. To confirm decreased sensitivity of α1D80A GlyRs to 
enhancing concentrations of zinc, additional glycine concentration-response 
curves were generated using the same protocol except that all MBS and glycine 
solutions contained 1 µM added zinc, which produces an approximately maximal 
enhancing effect of zinc on glycine-activated currents (Bloomenthal et al., 1994).   
Taurine Concentration-Response Curves.  Concentration-response curves 
for the GlyR partial agonist taurine were generated for wild type and mutant α1 
GlyRs.  A series of taurine concentrations (100 µM- 100 mM) was tested; each 
concentration was applied for ~30 sec and a 7 min washout period separated each 
application of taurine.  The amount of current elicited by each taurine 
concentration was calculated and recorded as a percentage of the maximal glycine 
effect.    
Zinc-dependent Modulation of Wild Type GlyRs by Ethanol.  The effects 
of three different enhancing concentrations of zinc (100 nM, 500 nM and 1 µM) 
on the modulation of wild type receptors by ethanol were tested.  Oocytes were 
first perfused with two ~15 sec applications of 10 mM glycine each followed by a 
7 min washout period.  The peak current elicited by the second application of 
glycine was considered to be the maximal response and was used to determine a 
concentration of glycine that produced ~5-10% (EC5-10) of the maximal 
glcyinergic effect.  This experimentally derived EC5-10 concentration of glycine 
was then applied and following a 7 min washout period, 200 mM ethanol was first 
applied alone for 1 min, then it was applied concurrently with the experimentally 
derived EC5-10 concentration of glycine for ~45 sec.  The EC5-10 concentration 
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of glycine was again applied alone for 45 sec following a 7 min washout.  This 
procedure was carried out first in regular MBS, then it was repeated in MBS with 
10 mM tricine to chelate contaminating free zinc, in MBS plus 100 nM added 
zinc, in MBS plus 500 nM added zinc, and in MBS plus 1 µM added zinc.  In all 
conditions, the effects of ethanol were determined as percent potentiation of the 
glycine EC5-10 response. 
Ethanol Sensitivity in Mutant vs. Wild Type GlyRs.  Oocytes expressing 
either wild type α1 or mutant α1 D80A GlyRs were first perfused with two ~15 
sec applications of 10 mM glycine each followed by a 7 min washout period.  The 
peak current elicited by the second application of glycine was considered to be the 
maximal response and was used to determine a concentration of glycine that 
produced ~5-10% (EC5-10) of the maximal glycinergic effect.  This 
experimentally derived EC5-10 concentration of glycine was then applied and 
following a 7 min washout period, ethanol was first applied alone for 1 min, then 
it was applied concurrently with the experimentally derived EC5-10 concentration 
of glycine for ~45 sec.  The EC5-10 concentration of glycine was again applied 
alone for 45 sec following a 7 min washout.  This protocol was used to test 50 
mM and 200 mM ethanol.   
To determine the effects of chelating contaminating zinc on ethanol 
modulation of wild type α1 and mutant α1D80A GlyRs lacking enhancement by 
physiological concentrations of zinc, we repeated the same protocol in the 
presence of 10 mM tricine, which was added to the buffer solution as previously 
described (McCracken et al., 2010).  Because the level of free zinc is very low in 
this solution, we refer to it as “zinc free”.  In addition, to test the hypothesis that 
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added zinc would produce the opposite effect of a zinc chelator, this procedure 
was repeated for testing ethanol sensitivity in MBS containing 100 nM added 
zinc.  In all three conditions, the effects of ethanol were determined as percent 
potentiation of the glycine EC5-10 response. 
GlyR Modulation by Non-alcohol Sedatives. The effects of flurazepam, 
ketamine, pentobarbital, and 0.6 mM isoflurane in MBS were tested on wild type 
α1 and mutant α1D80A GlyRs.  The same procedure that was used to test ethanol 
sensitivity was used to test wild type and mutant GlyR sensitivity to other non-
alcohol sedatives.    
Mouse Breeding and Genotyping  
Breeding pairs of heterozygous Glra1D80A KI mice (backcrossed to 
C57BL/6 for at least five generations) were provided by Dr. H. Betz (Max-Planck 
Institute, Frankfurt, Germany).  The mice used in this study were produced at The 
University of Texas from heterozygous breeding pairs.  Following weaning, mice 
were housed at The University of Texas Animal Resource Center on a 12 hr 
light/dark cycle (lights on at 7:00 AM) with ad libitum access to standard rodent 
chow and water.  All mice, male and female, used in behavioral tests were 
between eight and twelve weeks old and ethanol naïve at the start of each 
experiment and were used only once (i.e. animals were not used in more than one 
behavioral test).  Due to poor viability and testing limitations resulting from the 
functional impairments of homozygous Glra1D80A KI mice, only heterozygous 
KI animals and their wild type littermate controls were included in the behavioral 
experiments.  The protocols used for behavioral testing were approved by The 
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University of Texas Institutional Animal Care and Use Committee and were 
conducted in accordance with National Institutes of Health guidelines with regard 
to the use of animals in research. 
Alcohol Consumption and Preference (24 hr access) 
A standard two-bottle choice drinking protocol similar to those previously 
described (Blednov et al., 2003; 2012) was used.  Mice were individually housed 
and given a one-week acclimation period.  Two drinking tubes (one containing 
water and one containing an ethanol solution) were continuously available to 
mice.  The tubes were weighed and their left/right positions were alternated daily 
(to avoid side preference).  In addition, the mice were weighed every fourth day.  
Mice were offered 3% (v/v) ethanol versus water for two days.  This was repeated 
successively for 6%, 9%, 12%, and 15 % (v/v) ethanol.  The quantity of ethanol 
and water consumed by each mouse (g/kg body weight/ 24 hr) was calculated and 
the values for each respective concentration of ethanol were averaged.  
Throughout the experiment, estimates of spillage/evaporation were calculated 
daily from drinking tubes (one containing water and one containing the 
appropriate ethanol solution) placed in an empty cage on each row of the cage 
rack.    
Non-alcohol Tastant Consumption and Preference (24 hr access) 
In addition to ethanol, consumption of and preference for two other tastant 
solutions, saccharin and quinine, were tested in wild type and mutant KI mice to 
test for bitter or sweet taste preferences.  In a two-bottle choice paradigm, mice 
were serially offered saccharin (0.0165% and 0.033%) and quinine hemisulfate 
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(0.03 mM and 0.066 mM) and their intakes were calculated daily.  Each 
respective concentration was offered for two consecutive days, and the bottle 
positions were alternated daily.  For each tastant, the lower concentration was 
always presented first followed by the higher concentration, and one week 
separated tastant testing during which mice had access to two bottles, both 
containing water.   
Drug Preparation and Injection 
All drug solutions were prepared as previously described (Blednov et al., 
2011).  Ethanol (Aaper Alcohol and Chemical, Shelbyville, KY or Pharmco, 
Brookfield, CT) solutions were prepared in 0.9% saline (20% v/v) and injected 
i.p. at a dosing volume of 0.2 ml/10g of body weight.  Flurazepam (Sigma-
Aldrich, St. Louis, MO) and pentobarbital  (Sigma/RBI, Natick, MA) were 
dissolved in 0.9% saline and were injected i.p. at 0.01ml/g of body weight.  
Strychnine (Sigma-Aldrich, St. Louis, MO) was prepared in 0.9% saline and was 
injected i.p. at a volume of 10ml/kg of body weight. 
Loss of Righting Reflex (LORR) 
Wild type and KI mice were tested for sensitivity to the sedative effects of 
ethanol (3.4 and 3.8 g/kg) and other CNS depressants including flurazepam 
(225mg/kg), pentobarbital (50 mg/kg), and ketamine (175 mg/kg) using a 
standard duration of LORR (sleep time) assay as previously described for other 
GlyR KI mice (Blednov et al., 2012).  Once ataxic, mice were placed in the 
supine position in V-shaped plastic troughs until they were capable of righting 
themselves three time within 30 sec; sleep time was defined as the time from 
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when they were place in the supine position until they regained their righting 
reflex. 
Rotarod 
Mice were trained on a fixed speed (5.0 rpm) rotarod (Economex; 
Columbus Instruments, Columbus, OH).  Training was considered complete when 
mice could remain on the rotarod for 60 sec.  To test the effects of ethanol on 
motor coordination, wild type and KI mice were administered ethanol (2.0 g/kg 
i.p.) and 15 min post injection they were placed back on the rotarod.  Their 
latency to fall was recorded until they were capable of remaining on the rotarod 
for 60 sec.   
Acoustic Startle Response 
SR-LAB test stations and software (San Diego Instruments, San Diego, 
CA) were used to test acoustic startle responses in wild type and mutant KI mice.  
Startle responses elicited by a series of auditory stimuli were record as previously 
described (Findlay et al., 2003; Blednov et al., 2012).  First, mice were placed in 
Plexiglas holding chamber for a 5 min acclimation period.  Then, in the following 
8 min, mice were presented with seven trial types across five discrete blocks of 
trials for a total of 30 trials.  There was a 10-20 sec inter-trial interval.  To control 
for baseline movement, one trial type measured the response to no stimulus, 
whereas the remaining six trial types measured the response to startle stimuli.  
This consisted of 40 msec sound bursts of 90, 95,100, 105, 110, or 115 dB.  
Starting at the onset of startle stimuli, startle amplitude was measured every 1 
msec during a 65 msec period.  The six trial types were presented to mice in a 
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pseudorandom order such that each trial type was presented once within a block 
of six trials.  The maximum startle amplitude (Vmax) over this sampling period 
was taken as the dependent variable.  A background noise level of 70 dB was 
maintained throughout the duration of the test session.   
Strychnine-induced Convulsions 
Wild type and KI mice were injected with a series of doses of the GlyR 
antagonist strychnine to test for differences in chemically-induced seizure 
activity.  For each dose of strychnine, a group of five mice was used.  During 
testing, mice were individually placed into observation chambers (20 cm X 10 cm 
X 10 cm Plexiglas cage), and were continuously observed following injections of 
strychnine (up to 30 min post injection) for latency to clonic and tonic 
convulsions.  The data were recorded and tabulated as previously described 
(Blednov et al., 2012) as the number of mice exhibiting the behavioral signs as 
well as the latency to first seizure occurrence.  The dose of strychnine that elicited 
convulsive activity in 50% of the group (ED50) was calculated using linear 
regression analyses.   
Statistical Analysis 
For experiments in recombinant GlyRs, nonlinear regression analyses 
were performed to calculate glycine EC50 values and Hill coefficients for glycine 
concentration-response curves, and t-tests and one-way ANOVAs followed by 
post-hoc analyses were used to determined differences in ethanol sensitivity and 
the effects of other sedative agents.  In addition, two-way ANOVAs (with 
Dunnett’s or Bonferroni post hoc tests), Student’s t-tests, and linear regression 
 49 
analyses were conducted to detect differences between groups in the behavioral 
experiments.  Overall, statistical differences were determined at p< 0.05, and all 
analyses were conducted using GraphPad PRISM software (San Diego, CA).  
RESULTS 
Recombinant GlyRs Expressed in Oocytes 
Glycine Sensitivity.  We first generated agonist (glycine and taurine) 
concentration-response curves for α1 and α1D80A GlyRs expressed in oocytes to 
determine differences in agonist sensitivity.  For the full agonist glycine, 
introducing the D80A mutation in the α1 subunit resulted in a rightward shift in 
the glycine concentration-response curve for the mutant compared to wild type 
GlyRs (Figure 3.2A).  To confirm the results of previous studies that show that 
mutant α1D80A GlyRs have reduced sensitivity to enhancement of glycine-
activated currents by low micromolar and nanomolar concentrations of zinc, we 
also generated glycine concentration-response curves in the presence of 1 µM 
added zinc.  This concentration of zinc, which is approximately maximally 
enhancing on wild type GlyRs (Bloomenthal et al., 1994), did not produce any 
shifts in the glycine concentration-response curve of mutant α1D80A GlyRs 
indicating no enhancement of the glycine-activated currents. In addition, there 
was no significant difference in the maximal glycine-activated currents in mutant 





Figure 3.2: α1D80A glycine receptor sensitivity to agonists. 
Agonist concentration response curves for mutant α1D80A and wild type α1 
GlyRs.  A) A series of glycine concentrations (10µM- 10 mM) were tested on 
mutant and wild type GlyRs.  B) A series of taurine concentrations (100 µM- 100 
mM) were also tested. no significant difference in the maximal glycine-activated 
currents in mutant versus wild type receptors in either normal MBS or in the 
presence of 1 µM added zinc.   
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Taurine Sensitivity.  Concentration-response curves for the partial agonist taurine 
suggested that it might be less efficacious on mutant α1D80A GlyRs compared to 
wild type GlyRs, however, this trend was not statistically significant (Figure 
3.2B).    
Zinc Modulation of Ethanol Sensitivity in Wild Type GlyRs.  Emergent 
evidence shows the importance of zinc in determine the effects of ethanol on 
GlyRs and because the D80 position is among the known high affinity sites 
important for enhancement of GlyR function by low physiological concentrations 
of zinc, we tested the hypothesis that mutation of this site would produce changes 
in the effects of ethanol on mutant α1D80A GlyRs expressed in oocytes.  To do 
this, we first tested the effects of 200 mM ethanol on wild type α1 GlyRs with a 
series of different concentrations of zinc ranging from a zinc-free MBS solution 
that contained the zinc chelating agent tricine to 1 µM zinc to determine which 
concentration produced the greatest increase in ethanol enhancement.  
Manipulating the levels of zinc in our perfusion solutions significantly changed 
the magnitude of ethanol’s enhancing effect on wild type α1 GlyR function 
(Figure 3.3A).  In zinc-free MBS, which contained 10 mM tricine, 200 mM 
ethanol had the smallest degree of enhancement of glycine-activated currents.  In 
contrast, ethanol modulation of GlyR function was greatest in the presence of 100 
nM added zinc.  Intermediate degrees of enhancement were observed when the 
effects of 200 mM ethanol were tested in the presence of 500 nM and 1 µM added 
zinc.   
Ethanol Sensitivity of Mutant D80A GlyRs.  Next, we investigated whether 
mutation of the aspartate at position 80 to alanine in the α1 GlyR would result in 
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GlyRs with decreased sensitivity to ethanol.  The enhancement of wild type α1 
and mutant α1D80A GlyRs by 50 mM and 200 mM ethanol in standard MBS 
solutions was measured.  Figures 3.3B and 3.3C show that the mutant compared 
to wild type GlyRs demonstrated decreased sensitivity to 50 mM [t(7)= 2.422; p= 
0.0459] and 200 mM [t(14)= 2.358; p= 0.0334] ethanol, respectively.   
Zinc/Ethanol Interactions in Wild Type and D80A GlyRs.  To determine if 
the decreased ethanol sensitivity of the D80A mutant might be due to the loss of 
the enhancing effects of zinc on ethanol action, we subsequently tested the effects 
of the same ethanol concentrations (50 mM and 200 mM) in mutant and wild type 
receptors first in the presence of the chelating agent tricine and then in the 
presence of 100 nM added zinc, which in the previous experiment we determined 
to produce the greatest increase in the magnitude of ethanol’s effect on wild type 
α1 GlyRs.  Manipulating the concentrations of zinc present in our buffers did not 
change in the magnitude of ethanol enhancement of mutant α1D80A GlyRs by 
either 50 mM or 200 mM ethanol [for 50 mM ethanol: F(2,9)= 1.147; p= 0.3601; 
for 200 mM ethanol: F(2,12)= 0.6007; p= 0.5641] (Figure 3.3B and C). In 
contrast, for wild type GlyRs, the presence of tricine significantly decreased the 
degree of enhancement by 50 mM and 200 mM ethanol, and the opposite effect 
was observed such that 100 nM added zinc significantly increased the effects of 
both 50 mM and 200 mM ethanol on wild type GlyR function [for 50 mM 




Figure 3.3: α1D80A glycine receptor sensitivity to ethanol. 
Modulation of mutant D80A and wild type α1 GlyRs by ethanol in the presence 
and absence of zinc. A) The effects of 200 mM ethanol on α1 GlyRs were tested 
in standard MBS, in tricine, and in three added zinc conditions (100 nM, 500 nM, 
and 1 µM).  B) Modulation of D80A and wild type GlyRs by 50 mM ethanol was 
tested in standard MBS, in tricine, and in 100 nM added zinc.  Similarly, the 
modulation of D80A and wild type GlyRs by 200 mM ethanol was measured in 
three conditions: MBS, MBS with tricine, and MBS with added zinc.
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Sensitivity of Mutant D80A GlyRs to Other Sedative Agents.  In addition to 
ethanol, we tested the effects of other sedative agents on wild type α1 and 
α1D80A GlyRs.  There were no differences in the enhancement of wild type or 
mutant GlyRs by flurazepam, pentobarbital, ketamine, or isoflurane [t(7)= 0.5293; 
p= 0.6129]. 
Behavioral tests in GlyR KI Mice 
Mouse Breeding.  Heterozygous breeding pairs of Glra1D80A KI mice 
were used to produce the animals tested in this study.  Mice homozygous for the 
D80A mutation display low viability, and we used heterozygous Glra1D80A 
mice and their respective wild type litters mates all the behavioral tests conducted.  
More specifically, of 138 mice that we produced 46 mice or 33% were wild type 
(+/+), 71 mice or 52% were heterozygous (+/-) for the D80A mutation, and 21 
mice or 15% were Glra1D80A homozygotes (-/-).  Chi-square analysis of the 
number of mice we produced with each respective genotype reveals that the actual 
genotype ratios that we generated were significantly different than those predicted 
by Mendelian genetics [χ2(2, N= 138)= 9.174; p= 0.0102].  The small number of 
homozygotes that we were able to produce, were impaired in a manner that would 
have occluded reliable measurements in most of the behavioral tests that we 
conducted. 
Alcohol Consumption and Preference.  A continuous access, two-bottle 
choice drinking paradigm was used to test for differences in alcohol consumption 
and preference between D80A GlyR KI mice and wild type littermate controls.  
Female Glra1D80A mice consumed significantly less ethanol than wild type 
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females [main effect: F(4, 64)= 2.90; p= 0.0286; t(17)= 3.064; p< 0.05 at 9% 
ethanol] and also exhibited decreased preference for alcohol [F(4,64)= 9.52; p< 
0.0001].  However, this effect was sex-specific as there were no differences in 
ethanol consumption [F(4,85)= 1.06; p= 0.3813] or preference [F(4,85)= 0.70; p= 
0.5913] between male wild type and mutant mice. There were also no significant 
differences in total fluid intake detected between the two genotypes for males or 
females [for males: F(4,85)= 0.24; p= 0.9146; for females: F(4,64)= 0.30; p= 
0.8754 (Figure 3.4).   
Non-alcohol Tastant Consumption and Preference.  To test for differences 
between mutant and wild type mice with respect to sweet or bitter tastants, we 
used a continuous access two-bottle choice paradigm to measure saccharin and 
quinine consumption and preference.  There were no significant differences 
detected between D80A KI and wild type male or female mice for either 
saccharin consumption [for females: F(1,16)= 0.68; p= 0.4212; for males: 
F(1,16)= 0.04; p= 0.8532], preference [for females: F(1,16)= 0.84; p= 0.3718; for 
males: F(1,16)= 0.0; p= 0.9757], or total fluid intake [for females: F(1,16)= 0.47; 
p= 0.5018; for males: F(1,16)= 0.13; p= 0.7252] (Figure 3.5).  In addition, Figures 
3.6A and B show that female D80A KI and wild type mice did not differ in their 
consumption [F(1,16)= 0.0; p= 0.9662] or preference [F(1, 16)= 0.0; p= 0.9944] 
for quinine.  However, in this assay the mutant D80A mice did show less total 




Figure 3.4:  Ethanol consumption and preference in mutant and wild type mice.  
Ethanol consumption (g/kg/24hrs) and preference were measured in heterozygous 
D80A KI mice and their wild type littermates.  A and B) Both consumption and 
preference were decreased in female D80A mice.  However, this effect was sex-
dependent.  D and E) There were no differences in ethanol consumption or 
preference for wild type and D80A mutant mice.  C and F) Total fluid intake was 




Figure 3.5: Saccharin consumption and preference in mutant and wild type mice.  
Consumption (g/kg/24hrs) of and preference for the sweet tastant saccharin were 
tested in D80A and wild type mice.  Neither females nor males displayed 
differences in consumption (A and D).  Similarly, no differences in preference 
were detected (B and E).  C and F) There were no differences in total fluid intake 
in this assay.  
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Male mutant and wild type mice did not demonstrate any differences in either 
quinine consumption [F(1,16)= 0.24; p= 0.6344], preference [F(1, 16)= 0.59; p= 
0.4554], or total fluid intake [F(1,16)= 0.13; p= 0.7252] (Figure 3.6E, F, and G). 
Loss of Righting Reflex.  Differences between mutant and wild type mice 
in the duration of LORR was measured following the injection of four sedative 
agents, ethanol, flurazepam, pentobarbital, or  ketamine.  For ethanol (Figures 
3.7A and B), there was no effect of genotype on sleep time for either males 
[t(16)= 0.1491; p= 0.8834] or females [t(16= 1.979; p= 0.0652] (Figure 3.7A and 
B).  However, male D80A KI demonstrated increased LORR compared to their 
wild type male littermates in response to pentobarbital [t(8)= 4.008; p= 0.0039], 
flurazepam [t(9)= 10.56, p< 0.0001], and ketamine [t(10)= 7.211; p< 0.0001] 
(Figures 3.7C, E, and G).  Likewise, Figures 3.7D, F and H show that the same 
effect was observed in female mice in response to pentobarbital [ t(12)= 7.510; p< 
00.001], flurazepam [t(15)= 3.990; p= 0.0012], and ketamine [t(12)= 11.40; p< 
0.0001], respectively.   
Acoustic Startle Response.  Behavioral characterizations of other GlyR KI 
mice show that impairments in GlyR function are accompanied by changes in 
startle responses (Findlay et al., 2003; Blednov et al., 2012).  Therefore, we 
compared this behavior in D80A KI and wild type mice.  In both sexes, the 
mutant mice exhibited increased startle responses compared to wild type controls.  
There were not main effects for males [F(4, 110) = 0.67; p= 0.6113] or females 
[F(4,60)= 2.14; p= 0.0861].  
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Figure 3.6:  Quinine consumption and preference in mutant and wild type mice.  
Consumption (g/kg/24hrs) of and preference for the bitter tastant quinine were 
tested in D80A and wild type mice.  Neither females nor males displayed 
differences in consumption (A and D).  Similarly, no differences in preference 
were detected (B and E).  C) Female D80A had decreased total fluid intake 
compared to wild type mice.  However, there were no differences in total fluid 
intake for males in this assay.   
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Figure 3.7: Loss of righting reflex induced by sedative agents.   
The duration of loss of righting reflex (LORR) induced by ethanol, pentobarbital, 
flurazepam, and ketamine were measured in D80A KI and wild type mice.  A and 
B) There were no differences in ethanol sleep time between mutant and wild type 
mice.  However, both male and female D80A mice had increased durations of 
LORR induced by pentobarbital (C and D), flurazepam (E and F), and ketamine 
(G and H).  
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However, there were differences detected at individual decibel levels for males 
[t(24)= 2.833; p< 0.05; at 115 dB] and females [t(13)= 3.530; p< 0.01 at 110 dB; 
t(13)= 4.366; p< 0.01 at 115 dB] (Figures 3.8A and B).  In an additional series of 
experiments, we further tested whether ethanol modulation of acoustic startle 
responses was changed in mutant D80A KI mice and discovered that ethanol (0.5 
or 1.0 g/kg, i.p.) had no effect on startle responses of female [F(10, 222)= 0.10; 
p= 0.9998] and male [F(10, 156)= 0.67; p= 0.7488] mutant KI mice(Figure 3.8C 
and E).  However, both ethanol doses increased startle responses in male WT 
mice [t(25)= 2.739; p< 0.05 for 0.5 g/kg ethanol; t(25)= 2.812; p< 0.05 for 1.0 
g/kg ethanol] (Figure 3.8D), whereas only 0.5 g/kg ethanol increased startle 
responses in female WT mice [t(21)= 3.643; p< 0.01] (Figure 3.8F). 
Ethanol Rotarod.  To measure the motor-incoordinating effects of ethanol 
(2 g/kg, i.p.), we used the rotarod test .  This dose of ethanol impaired motor 
coordination, however, there were no measureable differences between female 
[F(7, 80)= 0.63; p= 0.7271] or male [F(9, 100)= 0.23, p= 0.9889] mutant and wild 
type mice in their respective recoveries from ethanol-induced incoordination (not 
shown).   
Strychnine Convulsions.  We measured tonic convulsions in wild type and 
mutant D80A KI mice induced by injections of the GlyR antagonist strychnine.  
There were no differences observed between wild type and KI mice in sensitivity 
(ED50) to tonic convulsions in either females (0.49 mg/kg for wild type vs. 0.54 
mg/kg for KI mice) or males (0.53 mg/kg for wild type vs. 0.59 for KI mice).   
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Figure 3.8: Acoustic startle responses in mutant and wild type mice.   
The data represent the maximum startle amplitude (Vmax) as a function of sound 
intensity in decibels (dB). A and B) The startle responses female and male D80A 
mice were increased compared to wild type controls.  The effects of ethanol on 
startle responses were also measured C and D) Ethanol increased the startle 
responses in male wild type, but not mutant D80A mice.  Likewise, female wild 
type mice had increased startle responses following injections of ethanol, but this 
was not observed in female D80A mice (E and F).   
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DISCUSSION 
Although the mechanism for zinc modulation of GlyR function is not 
completely understood, several amino acid residues located in the N-terminal 
domain of the α1 subunit responsible for the enhancing and inhibiting effects of 
zinc on GlyR function have been identified. The potentiating effects of zinc, 
generally seen at concentrations in the nanomolar to low micromolar range (<10 
μM), require high-affinity binding to amino acids at positions aspartate-80 (D80), 
threonine-151 (T151), glutamate-192 (E192), aspartate-194 (D194), and histidine-
215 (H215) (Laube et al. 2000; Miller et al. 2005b).   
In the present study, we first characterized in vitro the effects of 
introducing a mutation (D80A) at one of these high-affinity zinc binding sites.  
The decrease in affinity for sub-maximal glycine that we observed in the α1D80A 
mutant versus wild type GlyRs in this study is consistent with the effects of the 
zinc chelating agent tricine on decreasing glycine affinity in wild type receptors.  
McCracken et al. (2010) used tricine to eliminate low nanomolar concentrations 
of contaminating zinc and showed that this resulted in wild type GlyRs with right 
shifted glycine concentration-response curves of similar magnitude to the shifts 
observed for the α1D80A GlyRs tested in our current study.  In addition, the lack 
of difference observed between the taurine concentration response curves of wild 
type and mutant GlyRs is consistent with previous reports that the α1D80A 
mutation reduces enhancement of glycine-activated, but not taurine-activated 
currents by nanomolar and low micromolar concentrations of zinc (Laube et al., 
2000; Miller et al., 2005).  Furthermore, neither manipulating zinc concentrations 
nor introducing the D80A mutation produced changes in maximal glycine-
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activated currents, which serves as further evidence that zinc modulates GlyR 
function as an allosteric modulator.   
Although zinc concentrations in the brain exceed those present in other 
organs, most brain zinc is protein-bound (Mathie et al. 2006).  In its free or 
rapidly exchangeable form, zinc exists in cerebospinal fluid at tonic baseline 
concentrations ranging from approximately 5-25 nM (Frederickson et al. 2006).  
However, in the CNS, additional zinc is secreted from neurons (Takeda et al., 
2001), and this can result in transient zinc concentrations in excess of 1 µM 
following presynaptic release from GABAergic, glutamatergic, or glycinergic 
terminals (Frederickson et al. 2001).   
Because physiological concentrations of zinc  enhance the magnitude of 
ethanol’s effects on α1 GlyRs (McCracken et al., 2010), we tested whether 
mutant α1D80A GlyRs would confer decreased sensitivity to ethanol.  The 
enhancing effects of both 50 and 200 mM ethanol were reduced in mutant D80A 
GlyRs compared to wild type.   Just as the glycine concentration-response curves 
for α1D80A GlyRs resembled previously published wild type glycine 
concentration response-curves in the presence of the zinc chelator tricine, the 
reduced effects of ethanol enhancement on D80A mutant GlyRs also seemed to 
mimic the effects of ethanol observed in wild type α1 GlyRs in the presence of 
zinc chelation by tricine.   
To determine whether the reduced sensitivity of α1D80A GlyRs to 
ethanol was due to the elimination of the enhancing effects of zinc on ethanol 
action, we ran additional experiments in which the effects of ethanol were tested 
again in the presence of a zinc chelator (tricine) and in the presence of added zinc 
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(100 nM).  The results from these experiments showed that unlike wild type α1 
GlyRs in which chelating zinc decreases the effects of ethanol and adding 
physiological nanomolar zinc increases ethanol enhancement, manipulating the 
concentrations of zinc in which ethanol was tested on mutant α1D80A GlyRs did 
not change the magnitude of ethanol’s effect.  This suggests that the D80 position 
on the α1 GlyR subunit is critical for zinc modulation of ethanol action.  In 
addition, recent  pharmacological characterization of another GlyR α1 subunit 
mutant (M287L), also with decreased ethanol sensitivity, revealed that zinc did 
not enhance the effects of ethanol on mutant receptors at nanomolar 
concentrations that were suffice for increasing the magnitude of ethanol 
enhancement of receptor function in wild type GlyRs (Borghese et al., 2012).  
This further indicates that zinc is crucial in determining the sensitivity of GlyRs to 
ethanol and highlights the importance of including zinc in studies of ethanol 
receptor pharmacology.   
Several studies in rodent models of ethanol consumption provide 
compelling evidence indicating a role for GlyRs in alcohol drinking and ethanol 
reinforcement.  For example, bilateral infusions of glycine into the nucleus 
accumbens increase dopamine release and reduce ethanol drinking and 
preference, whereas infusions of the GlyR antagonist strychnine decrease 
dopamine output and increase ethanol intake (Molander et al., 2005).  Similarly, 
injections of two different glycine reuptake inhibitors, Org 25935 and Org 24598, 
each produce reductions in ethanol intake, and Org 25935 also reduces ethanol 
preference (Molander et al., 2007; Lido et al., 2011).   
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A logical extension of these findings is that increased brain zinc might 
increase ethanol consumption.  Indeed, genetic studies of alcohol drinking in mice 
show a negative correlation between zinc levels in brain and ethanol consumption 
(Jones et al., 2008). 
The apparent importance of both GlyRs and zinc in alcohol consumption 
paired with our in vitro data indicating a critical role for zinc in modulating 
ethanol action at GlyRs provided a rationale to study the potential role of zinc 
signaling at GlyRs in alcohol consumption and other alcohol-related behaviors.  
In addition, Glra1D80A KI mice, which contain the same zinc mutation that we 
characterized in vitro, provided us with an animal model for studies of 
zinc/ethanol interactions at the behavioral level.  From these experiments, a few 
distinct differences were observed between mutant KI and wild type mice.  First, 
D80A KI mice had decreased consumption of and preference for ethanol 
compared to their littermate controls.  However, this effect was only observed in 
females as the males showed no difference, but is consistent with the sex-
differences also observed in reduced alcohol consumption and preference for 
other GlyR KI mice previously studied (Table 2) (Findlay et al., 2003; Blednov et 
al., 2012).  Furthermore, our finding is also consistent with the genetic studies 
discussed above that revealed a correlation between levels of hippocampal zinc 
and alcohol consumption in female, but not in male mice (Jones et al., 2008).    
Additional behavioral differences between D80A KI and wild type mice include 
LORR induced by pentobarbital, flurazepam, and ketamine.  Both female and 
male mutant mice had increased sleep times following injections of the above 
drugs.  This effect also is consistent with the results of behavioral tests in other 
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GlyR mutant mice (Table 2) (Findlay et al., 2003; Blednov et al., 2012), 
suggesting that impairments in normal GlyR function potentially lead to 
compensatory changes in the receptors of other neurotransmitter systems such as 
GABA or glutamate.  Although we did not quantitate changes in GlyR expression 
levels in wild type versus D80A KI mice in this study, findings from the initial 
characterizations of mice homozygous for the mutation did not show differences 
in strychnine binding assays performed on tissue from mutant D80A and wild 
type mice suggesting that mice with the D80A mutation do not contain increased 
or decreased numbers of GlyRs (Hirzel et al., 2006). 
Multiple GlyR mutations in mammals, both naturally occurring and 
engineered, result in enhanced startle phenotypes (Findlay et al., 2003; 2005; 
Harvey et al., 2008; Blednov et al., 2012).  Like these other GlyR mutants, D80A 
KI mice also showed increased acoustic startle responses compared to wild type 
mice, which is consistent with results from the preliminary non-alcohol related 
behavioral characterizations of these mice (Hirzel et al., 2006).  In addition, we 
tested the effects of ethanol on startle responses and found that it had no effect on 
the startle responses of mutant KI mice, but did increase the startle responses of 
WT mice indicating that zinc signaling and the D80 position on the α1 GlyR 
maybe important in mediating ethanols effects on startle responses.   
Homozygous KI mice carrying each of the previously characterized GlyR 
KI mutations (S267Q, Q266I, and M287L) were not viable, and therefore all 
ethanol-related behavioral tests of these mutations have been limited to 














Test Behavior M F M F M F M F M F 
Startle reflex  ↑ ↑ ↑↑ ↑↑ ↑= ↑= ↑↑ ↑↑ ↑ ↑ 
Startle reflex EtOH 
activation 
↓ ↓ ↓ ↓     ↓ ↓ 
LORR 
(ethanol) 
3.8 g/kg ↓ =  ↑ ↑ ↑ = = ↑ = = 
LORR 
(pentobarbital) 
50 mg/kg ↑ ↑ = =     ↑↑ ↑↑ 
LORR 
(ketamine) 
175 mg/kg ↑ ↑ ↑ ↑  =   ↑ ↑ 
LORR 
(flurazepam) 
225 mg/kg ↑ ↑ ↑↑ ↑↑  =   ↑ ↑ 
 
 




= ↓ = ↓ = = ↑ = = ↓ 




↑ ↑ ↑ ↑ = ↑ ↑ ↑ = = 
2 Bottle choice 
(saccharin) 




= = ↓ = = = ↑ ↑ = = 
2 Bottle choice 
(quinine) 









= = ← ←   ←  ← = = 
Convulsions Strychnine ↑  ↑      = = 
 
Table 2:  Comparison of behavioral phenotypes for heterozygous GlyR KI mice.   
Increases in behavior are indicated by ↑, decreases are represented with↓, 
leftward shifts in time-dependent recovery curves are expressed as ←, and = 
denotes no difference between the respective mutant and their wild type littermate 
controls.  Data for M287L and Q2661 are from Blednov et al. (2102), Osc data 
are from Kling et al. (1997) and Findlay et al. (2003), and S267Q data are from 
Findlay et al. (2003).  There are conflicting findings for Osc mice as Kling et al. 
(1997) reported increases in startle, whereas Findlay et al. (2003) found no 
differences.  For blank spaces, there are no published reports characterizing the 
given behavioral phenotype for that particular genotype.  
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Likewise, we tested wild type and heterozygous Glra1D80A mice because our 
colony yielded a low number of homozygotes and the motor impairments of those 
that we did produce would have occluded measurements in the behavioral tests 
that we ultimately performed.  The overall level of impairment observed in 
homozygous D80A KI mice highlights the importance of GlyR modulation by 
endogenous zinc in normal neurological function.   
In this study, we focused on one of amino acid resides of the α1 GlyR 
subunit with known importance for the enhancing actions of zinc on GlyR 
function.  However, additional residues of the GlyR α1 subunit, in particular 
histidine-107 (H107), histidine-109 (H109), threonine-112 (T112), and threonine-
133 (T133) are thought to contribute to lower-affinity binding sites and are 
necessary for inhibition of GlyR function by higher micromolar concentrations of 
zinc (> 10 μM) (Harvey et al., 1999; Laube et al., 2000; Miller et al., 2005). The 
importance of zinc binding at lower affinity (GlyR inhibitory) sites is illustrated in 
instances of ischemia, seizure, trauma, and neurodegeneration, during which zinc 
levels are estimated to peak in the brain at concentrations in excess of 100 μM 
(Choi & Koh,1998; Doraiswamy & Finefrock, 2004).  Future studies focusing on 
these higher concentrations of zinc and the corresponding binding positions on the 
GlyR may be important for additional characterizations of zinc in modulating 
ethanol action at the GlyR.   
Overall, our findings demonstrate the significance of low physiological 
concentrations of zinc in modulating the effects of ethanol on GlyR function and 
more specifically the crucial role of the D80 position in the α1 GlyR subunit in 
regulating this effect both in vitro and in vivo.  In addition, the results from our 
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behavioral tests in mutant D80A GlyR KI mice provide additional evidence that 
impairments in GlyR function correspond to changes in alcohol-related behaviors.   
Finally, these data elucidate the role of zinc in determining alcohol action at 
GlyRs, and by better understanding the sites and mechanisms of alcohol action, 
we can ultimately develop more efficacious treatments for alcoholism and other 
alcohol-related health complications.   
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CHAPTER IV: Discussion, Implications, And Future Directions 
Despite zinc existing more abundantly in brain than any other organ of the 
body, previous investigations of the effects of ethanol on ion channel function 
have not examined the potential role of this endogenous agent in ethanol receptor 
pharmacology. The overall goal of this project was to address this issue by 
specifically investigating the effects of zinc on alcohol action at the GlyR using in 
vitro and in vivo techniques.  A zinc/ethanol interaction was first characterized in 
recombinant GlyRs, and then, a site of action underlying zinc modulation of 
ethanol action at GlyRs was examined using recombinant receptors containing a 
mutation at a known zinc-binding site (D80A).  In addition, behavioral studies of 
the effects of alcohol in mice containing zinc-insensitive mutant GlyRs were 
tested. 
The initial aim of this work was to test whether zinc is important for 
ethanol modulation of GlyR function.  Our preliminary work revealed that 
physiological (nanomolar) concentrations of zinc that correspond to the levels of 
zinc tonically present in cerebrospinal fluid act to enhance the magnitude of 
ethanol’s effect at α1 GlyR subunits (McCracken et al., 2010).   In this series of 
studies, we sought to extend these findings to other GlyR alpha subunits, α2 and 
α3, that are expressed throughout the brain and spinal cord (Baer et al., 2009; 
Jonsson et al., 2009).  As described in greater detail in chapter 2, our data 
demonstrate that nanomolar concentrations of zinc also act to enhance the effects 
of ethanol on α2 and α3 GlyRs.  For example, removing all zinc with the chelator 
tricine decreased ethanol modulation of these GlyRs, whereas adding nanomolar 
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concentrations of zinc increased the effects of ethanol as we previously observed 
in α1 GlyRs.  Prior to this work, there were no published reports of ethanol 
modulation of α3 GlyRs, however, in this study we showed that like the more 
thoroughly studied α1 and α2 GlyR subunits, α3 GlyRs are also allosterically 
modulated by intoxicating concentrations of ethanol and that the magnitude of 
ethanol’s effect on these channels is zinc-dependent.   
The findings from this work in combination with evidence from studies of 
GlyR gene and receptor membrane expression provide compelling evidence of the 
necessity for future investigations of the mechanisms and sites of action of 
ethanol to include or even primarily focus on α2 and α3 GlyRs.   For example, 
quantification of GlyR subunit mRNA levels (Table 1) demonstrates that of the 
GlyR alpha subunits present in brain, the α2 subunit predominates in the 
mammalian forebrain, which includes limbic and reward centers such as the 
nucleus accumbens and amygdala (Jonsson et al., 2009).  For example, Delaney et 
al. (2010) show that in the amygdala the levels of α2 subunit protein expression at 
cellular membranes is the highest of the GlyR alpha subunits expressed in this 
region suggesting that there is a greater abundance of actual receptors not just 
higher RNA message levels.  
Furthermore, studies that used glycine receptor pharmacology to 
manipulate ethanol consumption and reinforcement provide additional evidence 
that although a majority of past studies in the alcohol field have largely focused 




Table 3: Glycine receptor expression levels in brain.  
The mean mRNA expression levels (± standard deviations) for GlyR α1, α2, α3, 
and β subunits in the amygdala (Amyg), the anterior hypothalamus (Ant Hypo), 
the cingulate gyrus (Cing Gyrus), the caudate putamen (Caud Puta), the nucleus 
accumbens (Nuc Acc), the prefrontal cortex (PFC), the posterior hypothalamus 
(Post Hypo), and the ventral tegmental area (VTA) of Alko Alcohol (high 
drinking) and Non-Alcohol (low drinking) rats.  The expression levels represent 
values normalized to the mean of three reference genes (β-actin, GAPDH, and 
RPL19) (adapted from Jonsson et al., 2009).   
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Briefly, Soderpalm and colleagues conducted a series of experiments that show 
that increasing glycine levels in the nucleus accumbens (a brain region in which 
α2 and α3 GlyR subunits predominate relative to α1 GlyRs) of rodents either 
directly by bilateral injects of actual glycine or indirectly by injections of glycine 
uptake inhibitors (Org25935 and Org24598) results in increased levels of 
dopamine and decreased ethanol consumption.  Conversely, injections of the 
GlyR antagonist strychnine into the accumbens reduced dopamine output and 
increased alcohol drinking (Molander et al., 2005; 2007; Lido et al., 2011) 
suggesting a role for GlyRs in mediating the reinforcing effects of ethanol.  In a 
broader context, it has been proposed that GlyRs expressed in the mesolimbic 
dopamine system may be in the future a novel access point for studies of drug 
reinforcement (Soderpalm et al., 2009).  However, at this time much more 
experimentation is needed.   
Despite the predominance of α2 GlyRs, and to a lesser extent α3 GlyRs, 
in forebrain regions involved in alcohol-related behaviors, all GlyR KI mice that 
have been engineered to investigate the behavioral effects of mutant GlyRs with 
decreased ethanol sensitivity contain point mutations in the GlyR α1 subunit 
gene, Glra1.  With the exception of the D80A KI mice used as an animal model in 
this study, all others have contained single amino acid substitutions in the GlyR 
α1 subunit transmembrane domain (specifically in TM2 or TM3).  In addition, 
study of alcohol drinking and other related behaviors in animals homozygous for 
each of the respective mutations  were prevented by impaired viability (Findlay et 
al., 2002; 2003; 2005; Blednov et al., 2012).  For D80A KI mice, initial 
behavioral tests included mice homozygous for the mutation (Hirzel et al., 2006), 
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however, in this study, we were unable to study homozygous D80A mice due to  
our colony yielding a low number of homozygotes.  In addition, their seizure 
phenotype and impaired movement capabilities occluded reliable measurements 
in most behavioral tests.  
In contrast to the viability limitations and impaired phenotypes of mice 
with genetic alterations in the α1 GlyR subunit, both α2 and α3 knock-out mice 
are viable and overtly normal (Young-Pearse et al., 2006; Harvey et al., 2004).  
This combined with the expression levels of α2 and α3 GlyR subunits in 
forebrain regions involved in alcohol-related behaviors suggests that mice with 
alterations the GlyR α2 or α3 subunit genes may be more appropriate and 
valuable as animal models for future studies of GlyR function in mediating 
alcohol action and reinforcement.  In addition, a logical extension of the findings 
from studies of GlyR mutations in the α1 subunit with reduced ethanol sensitivity 
could be introducing corresponding mutations at the homologous positions in α2 
and α3 GlyRs.  These could then serve as substrates of interest for the future 
construction of GlyR KI mice.  Furthermore, an alternative approach to 
constructing and testing GlyR KI or KO mice would be to use RNAi to produce 
brain-region specific knock-down of a receptor subunit of interest.  This would 
circumvent the time, cost, and viability issues that have plagued studies of GlyR 
function in mediating alcohol-related behaviors in the context of constructing and 
testing GlyR KI mice.   
In addition to reports of GlyR agonists and antagonists, such as glycine 
and strychnine, modulating alcohol consumption in rodents, there is also recent 
evidence that acamprosate, a widely prescribed medication for the maintenance of 
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abstinence in alcohol dependence, may also reduce alcohol drinking via a GlyR-
mediated mechanism in the nucleus accumbens (Chau et al., 2010a; 2010b; Lido 
et al., 2011).  However, in initial studies of recombinant α1 GlyRs, there were no 
effects of acamprosate (Riley et al., 2008).  Subsequent studies of relative gene 
and receptor membrane expression levels of the GlyR α subunits in the 
mammalian forebrain revealed that the inconsistency between the published in 
vitro and in vivo findings may be a reflection of the predominant expression of α2 
and α3 GlyRs relative to α1 GlyRs in the nucleus accumbens.  Accordingly, we 
recently tested the hypothesis that α2 or α3 GlyRs, because they are the more 
abundant GlyR alpha subunits in the nucleus accumbens (Jonsson et al., 2009), 
would confer sensitivity to acamprosate in the absence of an effect on the α1 
subunit. Figure 4.1 shows that like the α1 GlyR subunit, neither the α2 nor the α3 
GlyR subunit is significantly modulated by acamprosate.  This suggests that the in 
vivo effects of acamprosate may be due to an indirect mechanism involving 
GlyRs, glycine, or glycine transporters rather than a direct effect on GlyRs 
expressed in the nucleus accumbens.  Alternatively, the effects observed in the 
nucleus accumbens could also be a downstream or indirect effect of action in 
another brain region with either efferent or afferent projections with the nucleus 
accumbens.  Regardless, this highlights the importance of developing improved 
GlyR-related pharmacotherapies with known mechanisms of action. 
Differences in expression levels are not the only distinguishing features 
among GlyR alpha subunits.  Several recent studies provide evidence of the 
functional differences among these proteins.  A profound example is the α3 GlyR 
subunit, which undergoes post-transcriptional modifications (RNA editing and 
 77 
splice variations) and is involved in inflammatory pain via modulation by 
prostaglandins (Meier et al., 2005; Eichler et al., 2009; Harvey et al., 2004).  
These respective features provide α3 GlyRs with distinguishing functional 
implications.  For example, α3 transcripts are RNA-edited to produce α3P185L 
GlyRs with significantly higher affinity for glycine than unedited α3 GlyRs 
(Meier et al., 2005) and localization and functional studies suggest that they are 
largely expressed extra-synaptically where they are involved in tonic inhibition 
(Eichler et al., 2008; 2009).  Sequence alignments of the GlyR subunits with other 
members of the Cys-loop superfamily reveal that the only other subunit that 
endogenously contains a leucine at the position homologous to 185 in GlyR α3 is 
the GABAA α6 subunit.  However, there is functional homology at this position 
with the GABAA α6 and δ subunits, which also contain aliphatic residues, valine 
and alanine respectively, at this position.  Like α3 GlyRs, these particular 
GABAA receptor subunits have high agonist sensitivities and are important for 
inhibitory neurotransmission outside of the synapse (Belelli et al., 2009).   
Although controversial, there are reports that these GABAA receptor 
subunits contain increased sensitivities to low concentrations of ethanol relative to 
other GABAA receptors (Wallner et al., 2003; 2006; Borghese et al., 2005).  Due 
to the functional distinctions between α3 GlyRs and the other GlyR alpha 
subunits and their similarities to particular GABAA receptors, we tested for 
preliminary differences in ethanol sensitivity between wild type α3 and mutant 
α3P185L GlyRs expressed in oocytes.  There were no differences in ethanol 
sensitivity at low to moderate concentrations (20 and 50 mM) of ethanol between 
wild type and mutant α3 receptors.  
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Figure 4.1.  Acamprosate modulation of α2 and α3 GlyRs. 
The effects of 1 and 10 µM acamprosate were tested on A) α2 and B) α3 GlyRs 
expressed in Xenopus oocytes.  Acamprosate was pre-applied for 1 min and then 
was concurrently applied with an EC5 concentration of glycine for 45 sec.  The 
data represent percent potentiation of the glycine-activated (EC5) currents.  
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This is in contrast to the reports that suggest α4, α6, and δ containing GABAA 
receptors confer high sensitivity to low concentrations of ethanol (Wallner et al., 
2003; 2006; but see also Borghese et al., for conflicting results).  In addition, it 
suggests that edited α3 GlyRs may be only functionally similar to a subset of 
GABAA receptors in terms of agonist sensitivity and extra synaptic localization, 
but that amino acid residues of the N-terminal domain Loop 2 region are in fact 
critical for determining high sensitivity to low ethanol concentrations.  This is 
further supported by findings from a GlyR α1 receptor chimera containing the 
Loop 2 region of GABAA δ receptors with sensitivity to low millimolar 
concentrations of ethanol (Perkins et al., 2009).  Consequently, further 
pharmacological and functional studies of edited versus unedited α3 GlyRs may 
contribute valuable insights into the sites and mechanisms of ethanol action due to 
their similarities and differences to both GABAA and other glycine receptors. 
The second aim of this study was to explore a possible site of action 
important for zinc modulation of ethanol action at the GlyR.  Although we do not 
have a detailed understanding of the mechanism by which zinc biphasically 
modulates GlyR function, several amino acid residues in the extracellular N-
terminal domain of the α1 GlyR subunit are critical for both the enhancing and 
inhibiting effects of zinc on glycine-activated currents.  As described in detail in 
earlier chapters, these include positions D80, T151, E192, D194, and H215 for 
zinc enhancement and positions H107, H109, T112, and T133 for zinc inhibition 
(Laube et al., 2000; Miller et al., 2005b).  The D80 position was our initial 
candidate position for investigation as it was the original amino acid residue that 
was shown to reduce zinc enhancement of glycine-activated currents when 
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mutated (Laube et al., 2000).  In addition, the availability of D80A KI mice 
(Hirzel et al., 2006) provided the opportunity to ultimately expand any findings 
from in vitro experiments to include behavioral studies of the potential 
importance of zinc signaling at GlyRs in alcohol consumption and related 
behaviors.   
Mutation of the D80 position to alanine resulted in GlyRs with altered 
responses to glycine and ethanol that closely resembled findings that we 
published previously demonstrating the effects of chelating  contaminating zinc 
on glycine and ethanol responses in wild type α1 GlyRs.  Both the addition of 
tricine to our buffer solutions and the introduction of the D80A mutation resulted 
in rightward shifts in the glycine concentration-response curves and reduced 
enhancement of GlyR function by ethanol.  However, in mutant α1D80A GlyRs 
the addition of nanomolar concentrations of zinc did not enhance the magnitude 
of ethanol’s effect as it did at wild type GlyRs.  In addition, chelating zinc with 
tricine did not reduce the degree of enhancement of GlyR function by ethanol as it 
did in wild type GlyRs.  Together these findings suggest that nanomolar 
concentrations of zinc are necessary for modulating ethanol action the GlyR, and 
more specifically they suggest that the D80 position is crucial in mediating 
zinc/ethanol interactions at the GlyR.   
Although our findings demonstrate that the D80 position is important for 
zinc enhancement of ethanol modulation at GlyRs, there are some limitations that 
could be addressed in the future with additional experiments.  For example, there 
are other amino residues on the α1 GlyR subunit (T151, E192, D194, and H215) 
that are also important for the enhancing effects of zinc (Miller et al., 2005).  The 
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effects of introducing mutations at these alternative zinc sites on ethanol 
modulation of GlyR function have not been tested, and therefore the possibility 
exists that altering any of the previously identified high-affinity zinc binding sites 
on the GlyR could produce results similar to those we observed in mutant D80A 
GlyRs, and therefore zinc/ethanol interactions may not be specific to the D80 
position.  In addition, the possibility cannot be excluded that there are additional 
sites on the GlyR that are important for zinc enhancement of function, but that 
have not yet been identified.  Finally, other studies of zinc action at ligand-gated 
ion channels have suggested tetradentate coordination between zinc and the 
protein (Trudell et al., 2008).  The high-affinity zinc sites that were not included 
in this study (T151, E192, D194, and H215) are proposed to contribute to a zinc-
binding pocket (Miller et al., 2005) and are consistent with the idea of zinc 
binding to the receptor in a tetradentate manner.  However, there are no residues 
near D80 that are postulated to similarly participate in the coordination of zinc 
binding in this region of the GlyR (Laube et al., 2000).    
Another caveat of zinc-dependent ethanol modulation of GlyR function is 
that zinc exerts biphasic effects on GlyR function.  Basal levels of tonic zinc and 
synaptic zinc are estimated in the nanomolar to low micromolar range 
(Frederickson et al., 2006; but there are neurological events in which brain zinc 
levels exceed 10 µM and zinc levels in this range inhibit GlyR function via action 
at several sites (H107, H109, T112, and T133) with lower affinity for zinc 
binding.  Neither the effects of higher (micromolar) zinc concentrations nor the 
effects of introducing mutations at any of these low affinity sites on ethanol action 
at the GlyR have been studied.  This is potentially an important future direction 
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for future studies of zinc/ethanol interactions at the GlyR especially in light of our 
data in Chapter Three.  We tested the effects of adding a series of enhancing zinc 
concentrations (100 nM, 500 nM, and 1 µM) on ethanol modulation of wild type 
α1 GlyRs, and our results suggested that ethanol-bound GlyRs may display left-
shifted zinc curves such the ethanol effects were largest in the presence of 100 nM 
zinc and decreased with each of the two higher zinc concentrations.  In the future, 
investigations of the effects of a wider range of zinc concentrations and other 
known zinc binding positions could provide valuable insights into zinc 
modulation of ethanol action.   
The findings from this study provide evidence that zinc is critical in 
determining the magnitude of ethanol’s effects at GlyRs.  However, this is not an 
exclusive example of ethanol and divalent cations acting to cooperatively 
modulate ion channel function.  For example, zinc chelation reduces the action of 
ethanol at NMDA receptors (Woodward & Smothers, 2003), and adding zinc 
increases the effects of ethanol action at NMDA receptors (Chandler et al., 1994).  
However, Chu et al. (1995) reported that zinc has no effect on ethanol modulation 
of NMDA receptor function. 
In addition, magnesium enhances ethanol inhibition of NMDA receptors 
(Jin et al., 2008).  Furthermore, there are proteins other than ion channels at which 
ethanol action is determined by zinc.  Notably, alcohol dehydrogenase requires 
the co-binding of zinc with ethanol to catalyze enzymatic activity (Kang et al., 
2012).   
In addition to zinc, there are other known endogenous agents that 
modulate GlyR function.  These include G-protein βγ subunits (Yevenes et al., 
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2003), which are suggested in addition to G-protein α(s) to be important for 
ethanol modulation of GlyR function (Yevenes et al., 2008; Guzman et al., 2009; 
Yevenes et al., 2010; 2011a).  Other endogenous modulators of GlyR function 
include prostaglandin E2 (selective for α3 GlyRs) and endocannabinoids (Harvey 
et al., 2004; Yevenes et al., 2011b).  Recent evidence also suggests that 
cannabinoids produce analgesic effects due to action at α3 GlyRs (Xiong et al., 
2011).  Notably, neither prostaglandins nor endocannabinoids have been studied 
in combination with ethanol.    
The third aim of this study was to evaluate the effects of a zinc-insensitive 
GlyR mutation on alcohol consumption and other related behavioral tests in mice.  
Heterozygous D80A KI mice served as an animal model that allowed us to 
expand our findings from in vitro experiments of recombinant α1D80A GlyRs to 
alcohol-related behavioral tests in vivo.  From these experiments, a few distinct 
differences were observed between mutant KI and wild type mice.  First, D80A 
KI mice had decreased consumption of and preference for ethanol compared to 
their littermate controls.  However, this effect was only observed in females as the 
males showed no difference, but is consistent with the sex-differences also 
observed in reduced alcohol consumption and preference for other GlyR KI mice 
previously studied (Findlay et al., 2003; 2005; Blednov et al., 2012).  
Furthermore, our finding is also consistent with genetic studies that reveal a 
correlation between levels of hippocampal zinc and alcohol consumption in 
female, but not in male mice (Jones et al., 2008).   However, it is difficult to 
interpret whether the behavioral changes observed in the D80A KI mice are due 
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to a general impairment in GlyR function, a decrease in ethanol modulation, a 
decrease in zinc signaling, or some combination of these factors.   
Additional behavioral differences between D80A KI and wild type mice 
include LORR induced by pentobarbital, flurazepam, and ketamine.  Both female 
and male mutant mice had increased sleep times following injections of the above 
drugs.  This effect also is consistent with the results of behavioral tests in other 
GlyR mutant mice (Findlay et al., 2003; Blednov et al., 2012), suggesting that 
impairments in normal GlyR function potentially lead to compensatory changes in 
the receptors of other neurotransmitter systems such as GABA or glutamate.  
Although we did not quantitate changes in GlyR expression levels in wild type 
versus D80A KI mice in this study, findings from the initial characterizations of 
mice homozygous for the mutation did not show differences in strychnine binding 
assays performed on tissue from mutant D80A and wild type mice suggesting that 
mice with the D80A mutation do not contain increased or decreased numbers of 
GlyRs (Hirzel et al., 2006).  Because changes in LORR induced by pentobarbital, 
flurazepam, and ketamine are a common behavioral characteristic shared by all 
GlyR KI mice that have been tested (Findlay et al., 2003; Blednov et al., 2012), it 
seems that the changes in sleep time is perhaps a likely consequence of general 
impairments in GlyR function as opposed to specific behavioral effects of any 
particular mutation. 
Although there are no recent reports of brain zinc levels in human 
alcoholics, earlier attempts to study zinc levels in chronic heavy drinkers 
suggested that alcoholism is associated with low serum and brain levels of zinc 
(Mezano & Carlen, 1994).  However, there are conflicting accounts in which 
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some cite low levels of brain zinc in alcoholics, whereas others report no 
differences between alcoholics and controls (Khan et al., 1984).  In these early 
reports, there are confounds due to methodical limitations, but also confounds 
often associated with postmortem alcoholic tissue such as poly drug use and 
comorbid conditions.  Despite this, the initial low brain zinc hypothesis in 
alcoholism is in agreement with more recent genetic studies in mice that found an 
inverse relationship between hippocampal zinc levels and alcohol consumption 
(Jones et al., 2008).  In recent years, newer quantification methods for measuring 
unbound versus protein bound zinc have enabled studies to quantify tonic levels 
of free zinc in cerebrospinal fluid, whereas previously used methodologies strictly 
measured total or protein bound zinc (Frederickson et al., 2006).  By using newer 
technologies, it’s possible that the early hypothesis that alcoholics contain low 
levels of brain zinc could be revisited such that doing so may resolve the formerly 
conflicting findings.   
The importance of zinc signaling at GlyRs for normal neurological 
function was described in earlier chapters in the context of the impairments of 
homozygous and heterozygous D80A KI mice.  However, the significance of zinc 
homeostasis for proper brain function extends beyond the scope of this study and 
is more broadly evident in a large list of disorders with which zinc dysregulation 
can be associated.  These include Parkinson’s, Alzheimer’s, schizophrenia, 
attention deficit and hyperactivity disorder, depression, amyotrophic lateral 
sclerosis, Down’s syndrome, multiple sclerosis, Wilson’s disease, and Pick’s 
disease.  In addition, more transient alterations in brain zinc have been described 
in epilepsy, traumatic brain injury, and even alcoholism (Grabrucker et al., 2011).  
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Accordingly, the development of zinc-related pharmacotherapies could have a 
widespread impact.   
Overall, the findings from this study demonstrate that the effects of 
ethanol at GlyRs (α1, α2 and α3) are zinc-dependent, and the implications of 
these findings are multi-faceted.  For example, future studies of ethanol action at 
recombinant GlyRs should account for contaminating levels of zinc as they are 
suffice for affecting modulation by ethanol.  In addition, our data highlight that 
understanding zinc/ethanol interactions is necessary in ultimately defining the 
mechanism of action of ethanol at the GlyR.  Furthermore, findings from our 
behavioral tests in GlyR KI mice containing the zinc-insensitive D80A mutation 
indicate that normal GlyR function and zinc signaling are important for alcohol 
consumption and other related behavioral tests.  Ultimately, by better 
understanding the sites and mechanisms by which ethanol produces its 
intoxicating effects, improved pharmacotherapies and other treatment options can 
be developed for the treatment of alcohol-related disorders.   
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